JP7385643B2 - Powder composition for promoting blood flow, relaxation, and improving athletic performance, its manufacturing method, and its use - Google Patents
Powder composition for promoting blood flow, relaxation, and improving athletic performance, its manufacturing method, and its use Download PDFInfo
- Publication number
- JP7385643B2 JP7385643B2 JP2021212987A JP2021212987A JP7385643B2 JP 7385643 B2 JP7385643 B2 JP 7385643B2 JP 2021212987 A JP2021212987 A JP 2021212987A JP 2021212987 A JP2021212987 A JP 2021212987A JP 7385643 B2 JP7385643 B2 JP 7385643B2
- Authority
- JP
- Japan
- Prior art keywords
- powder
- powder composition
- present
- subject
- test
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000843 powder Substances 0.000 title claims description 202
- 239000000203 mixture Substances 0.000 title claims description 128
- 230000017531 blood circulation Effects 0.000 title claims description 48
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- 230000001737 promoting effect Effects 0.000 title description 30
- 230000037147 athletic performance Effects 0.000 title description 27
- 210000004556 brain Anatomy 0.000 claims description 35
- 229910052705 radium Inorganic materials 0.000 claims description 35
- HCWPIIXVSYCSAN-UHFFFAOYSA-N radium atom Chemical compound [Ra] HCWPIIXVSYCSAN-UHFFFAOYSA-N 0.000 claims description 35
- 239000000463 material Substances 0.000 claims description 30
- 238000010304 firing Methods 0.000 claims description 24
- 229910052732 germanium Inorganic materials 0.000 claims description 22
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 claims description 21
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 18
- 229910052802 copper Inorganic materials 0.000 claims description 18
- 239000010949 copper Substances 0.000 claims description 18
- 239000003973 paint Substances 0.000 claims description 18
- 239000004744 fabric Substances 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 16
- 229910052710 silicon Inorganic materials 0.000 claims description 15
- 239000010703 silicon Substances 0.000 claims description 15
- 239000000835 fiber Substances 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 238000010000 carbonizing Methods 0.000 claims description 2
- 238000012360 testing method Methods 0.000 description 116
- 230000000694 effects Effects 0.000 description 91
- 238000005259 measurement Methods 0.000 description 47
- 239000003610 charcoal Substances 0.000 description 37
- 238000000034 method Methods 0.000 description 35
- 210000001015 abdomen Anatomy 0.000 description 34
- 239000000976 ink Substances 0.000 description 32
- 210000005252 bulbus oculi Anatomy 0.000 description 31
- 210000005036 nerve Anatomy 0.000 description 22
- 230000033001 locomotion Effects 0.000 description 21
- 230000003247 decreasing effect Effects 0.000 description 20
- 238000011156 evaluation Methods 0.000 description 20
- 238000007639 printing Methods 0.000 description 18
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 14
- 230000007423 decrease Effects 0.000 description 14
- 238000010586 diagram Methods 0.000 description 14
- 238000001931 thermography Methods 0.000 description 13
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 11
- 241000196324 Embryophyta Species 0.000 description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- 230000008859 change Effects 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- 241000209094 Oryza Species 0.000 description 9
- 235000007164 Oryza sativa Nutrition 0.000 description 9
- 230000002354 daily effect Effects 0.000 description 9
- 239000010903 husk Substances 0.000 description 9
- 210000003739 neck Anatomy 0.000 description 9
- 235000009566 rice Nutrition 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 210000003403 autonomic nervous system Anatomy 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 210000002414 leg Anatomy 0.000 description 8
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 8
- 230000036760 body temperature Effects 0.000 description 7
- 238000009529 body temperature measurement Methods 0.000 description 7
- 238000013461 design Methods 0.000 description 7
- 230000001976 improved effect Effects 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 230000004913 activation Effects 0.000 description 6
- 210000001508 eye Anatomy 0.000 description 6
- 230000005484 gravity Effects 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 230000002040 relaxant effect Effects 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 230000000386 athletic effect Effects 0.000 description 5
- 230000003750 conditioning effect Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 210000003128 head Anatomy 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 210000004126 nerve fiber Anatomy 0.000 description 4
- 239000000123 paper Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 230000000087 stabilizing effect Effects 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- 210000000689 upper leg Anatomy 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000010439 graphite Substances 0.000 description 3
- 229910002804 graphite Inorganic materials 0.000 description 3
- 210000004394 hip joint Anatomy 0.000 description 3
- 238000009434 installation Methods 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 210000003007 myelin sheath Anatomy 0.000 description 3
- 210000000578 peripheral nerve Anatomy 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- 241001330002 Bambuseae Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 239000005749 Copper compound Substances 0.000 description 2
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 2
- 206010016173 Fall Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- PLEZGBHMSVTPPQ-UHFFFAOYSA-N [O-2].[Ra+2] Chemical compound [O-2].[Ra+2] PLEZGBHMSVTPPQ-UHFFFAOYSA-N 0.000 description 2
- 208000003464 asthenopia Diseases 0.000 description 2
- 210000000467 autonomic pathway Anatomy 0.000 description 2
- 210000003050 axon Anatomy 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- 238000002485 combustion reaction Methods 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 150000001880 copper compounds Chemical class 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 2
- 239000011162 core material Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- YBMRDBCBODYGJE-UHFFFAOYSA-N germanium dioxide Chemical compound O=[Ge]=O YBMRDBCBODYGJE-UHFFFAOYSA-N 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000001624 hip Anatomy 0.000 description 2
- 230000009700 hormesis effect Effects 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- -1 radium oxide Chemical class 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 239000005060 rubber Substances 0.000 description 2
- 210000000323 shoulder joint Anatomy 0.000 description 2
- 150000003377 silicon compounds Chemical class 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- DFGKGUXTPFWHIX-UHFFFAOYSA-N 6-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]acetyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)C1=CC2=C(NC(O2)=O)C=C1 DFGKGUXTPFWHIX-UHFFFAOYSA-N 0.000 description 1
- 206010054196 Affect lability Diseases 0.000 description 1
- IHLDFUILQQSDCQ-UHFFFAOYSA-L C(C)(=O)[O-].[Ge+2].C(C)(=O)[O-] Chemical class C(C)(=O)[O-].[Ge+2].C(C)(=O)[O-] IHLDFUILQQSDCQ-UHFFFAOYSA-L 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010016326 Feeling cold Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- MRLQSGZHMHONNG-UHFFFAOYSA-K P(=O)([O-])([O-])[O-].[Ge+3] Chemical compound P(=O)([O-])([O-])[O-].[Ge+3] MRLQSGZHMHONNG-UHFFFAOYSA-K 0.000 description 1
- DZKUVVFEQHCDSK-UHFFFAOYSA-N P([O-])([O-])[O-].[Ge+3] Chemical compound P([O-])([O-])[O-].[Ge+3] DZKUVVFEQHCDSK-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000253999 Phasmatodea Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- FSYYCDYDQQAUCW-UHFFFAOYSA-L [F-].[F-].[Ra+2] Chemical compound [F-].[F-].[Ra+2] FSYYCDYDQQAUCW-UHFFFAOYSA-L 0.000 description 1
- QFBYBEDCELVEAJ-UHFFFAOYSA-L [Ge+2].[O-]C1=CC=CC=C1.[O-]C1=CC=CC=C1 Chemical class [Ge+2].[O-]C1=CC=CC=C1.[O-]C1=CC=CC=C1 QFBYBEDCELVEAJ-UHFFFAOYSA-L 0.000 description 1
- VIUODKCIIYIXHC-UHFFFAOYSA-L [I-].[I-].[Ra+2] Chemical compound [I-].[I-].[Ra+2] VIUODKCIIYIXHC-UHFFFAOYSA-L 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- ARVNHJBMBBFPCP-UHFFFAOYSA-L [OH-].[OH-].[Ra+2] Chemical compound [OH-].[OH-].[Ra+2] ARVNHJBMBBFPCP-UHFFFAOYSA-L 0.000 description 1
- YPWICUOZSQYGTD-UHFFFAOYSA-L [Ra+2].[O-]C([O-])=O Chemical compound [Ra+2].[O-]C([O-])=O YPWICUOZSQYGTD-UHFFFAOYSA-L 0.000 description 1
- MXQFUMUIEZBICJ-UHFFFAOYSA-L [Ra+2].[O-]S([O-])(=O)=O Chemical compound [Ra+2].[O-]S([O-])(=O)=O MXQFUMUIEZBICJ-UHFFFAOYSA-L 0.000 description 1
- BJVOQWSICFBCLU-UHFFFAOYSA-N [S-2].[Ra+2] Chemical compound [S-2].[Ra+2] BJVOQWSICFBCLU-UHFFFAOYSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000036982 action potential Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000004566 building material Substances 0.000 description 1
- GGHTWSNOKADVAG-UHFFFAOYSA-N butan-1-olate germanium(4+) Chemical compound [Ge+4].CCCC[O-].CCCC[O-].CCCC[O-].CCCC[O-] GGHTWSNOKADVAG-UHFFFAOYSA-N 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 229910001779 copper mineral Inorganic materials 0.000 description 1
- BWFPGXWASODCHM-UHFFFAOYSA-N copper monosulfide Chemical compound [Cu]=S BWFPGXWASODCHM-UHFFFAOYSA-N 0.000 description 1
- RFKZUAOAYVHBOY-UHFFFAOYSA-M copper(1+);acetate Chemical compound [Cu+].CC([O-])=O RFKZUAOAYVHBOY-UHFFFAOYSA-M 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- BERDEBHAJNAUOM-UHFFFAOYSA-N copper(I) oxide Inorganic materials [Cu]O[Cu] BERDEBHAJNAUOM-UHFFFAOYSA-N 0.000 description 1
- AQMRBJNRFUQADD-UHFFFAOYSA-N copper(I) sulfide Chemical compound [S-2].[Cu+].[Cu+] AQMRBJNRFUQADD-UHFFFAOYSA-N 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- WIVXEZIMDUGYRW-UHFFFAOYSA-L copper(i) sulfate Chemical compound [Cu+].[Cu+].[O-]S([O-])(=O)=O WIVXEZIMDUGYRW-UHFFFAOYSA-L 0.000 description 1
- 229940076286 cupric acetate Drugs 0.000 description 1
- 229960003280 cupric chloride Drugs 0.000 description 1
- 229960004643 cupric oxide Drugs 0.000 description 1
- 229940045803 cuprous chloride Drugs 0.000 description 1
- KRFJLUBVMFXRPN-UHFFFAOYSA-N cuprous oxide Chemical compound [O-2].[Cu+].[Cu+] KRFJLUBVMFXRPN-UHFFFAOYSA-N 0.000 description 1
- 229940112669 cuprous oxide Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- FSBVERYRVPGNGG-UHFFFAOYSA-N dimagnesium dioxido-bis[[oxido(oxo)silyl]oxy]silane hydrate Chemical compound O.[Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O FSBVERYRVPGNGG-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- CTCOPPBXAFHGRB-UHFFFAOYSA-N ethanolate;germanium(4+) Chemical compound [Ge+4].CC[O-].CC[O-].CC[O-].CC[O-] CTCOPPBXAFHGRB-UHFFFAOYSA-N 0.000 description 1
- CIENLGXGFYBTAO-UHFFFAOYSA-N ethene;germanium Chemical group [Ge].C=C CIENLGXGFYBTAO-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 230000004424 eye movement Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000005021 gait Effects 0.000 description 1
- 150000002291 germanium compounds Chemical class 0.000 description 1
- 229940119177 germanium dioxide Drugs 0.000 description 1
- IBENSVMKFVWLLF-UHFFFAOYSA-N germanium(4+) methanolate Chemical compound [Ge+4].[O-]C.[O-]C.[O-]C.[O-]C IBENSVMKFVWLLF-UHFFFAOYSA-N 0.000 description 1
- GGQZVHANTCDJCX-UHFFFAOYSA-N germanium;tetrahydrate Chemical compound O.O.O.O.[Ge] GGQZVHANTCDJCX-UHFFFAOYSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000018883 loss of balance Diseases 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000012778 molding material Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000005037 parasympathetic nerve Anatomy 0.000 description 1
- 210000004417 patella Anatomy 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-M phenolate Chemical compound [O-]C1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-M 0.000 description 1
- 229940031826 phenolate Drugs 0.000 description 1
- ACVYVLVWPXVTIT-UHFFFAOYSA-M phosphinate Chemical compound [O-][PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-M 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 208000024335 physical disease Diseases 0.000 description 1
- 230000036314 physical performance Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- GIKWXTHTIQCTIH-UHFFFAOYSA-L radium bromide Chemical compound [Br-].[Br-].[Ra+2] GIKWXTHTIQCTIH-UHFFFAOYSA-L 0.000 description 1
- 229940075451 radium bromide Drugs 0.000 description 1
- 229910001624 radium bromide Inorganic materials 0.000 description 1
- RWRDJVNMSZYMDV-UHFFFAOYSA-L radium chloride Chemical compound [Cl-].[Cl-].[Ra+2] RWRDJVNMSZYMDV-UHFFFAOYSA-L 0.000 description 1
- 229910001630 radium chloride Inorganic materials 0.000 description 1
- 150000003256 radium compounds Chemical class 0.000 description 1
- 229910001636 radium fluoride Inorganic materials 0.000 description 1
- 229910001642 radium iodide Inorganic materials 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000011257 shell material Substances 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 230000037078 sports performance Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 210000002820 sympathetic nervous system Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229910002029 synthetic silica gel Inorganic materials 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)
- Paints Or Removers (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
- Radiation-Therapy Devices (AREA)
Description
特許法第３０条第２項適用 ウェブサイトのアドレス：ｈｔｔｐｓ：／／ｃａｍｐ－ｆｉｒｅ．ｊｐ／ｐｒｏｊｅｃｔｓ／ｖｉｅｗ／３４４４６８ ウェブサイトの掲載日 ： 令和３年１月５日 〔刊行物等〕 ウェブサイトのアドレス：ｈｔｔｐｓ：／／ｎａｔｕｒａｌａｂ．ｔｈｅｓｈｏｐ．ｊｐ／ ｈｔｔｐｓ：／／ｎａｔｕｒａｌａｂ．ｔｈｅｓｈｏｐ．ｊｐ／ｃａｔｅｇｏｒｉｅｓ／３２２５０６０ ウェブサイトの掲載日 ： 令和３年１月８日 〔刊行物等〕ウェブサイトのアドレス：ｈｔｔｐｓ：／／ｂｅｎｅｃｈａｎ．ｓｈｏｐ／ｔｋｙ９５８５１－００２／ ウェブサイトの掲載日 ： 令和３年３月２４日 〔刊行物等〕ウェブサイトのアドレス：ｈｔｔｐｓ：／／ｗｗｗ．ａｍａｚｏｎ．ｃｏ．ｊｐ／スパオール血流改善はらまき（スパオール） －グレー／ｄｐ／Ｂ０９１ＰＪ３ＹＫＹ ウェブサイトの掲載日 ： 令和３年４月１日 〔刊行物等〕 ウェブサイトのアドレス：ｈｔｔｐｓ：／／ａｌｌｅｓ－ｉｎｃ．ｃｏｍ／ｓｐａｏｒｅ／ ウェブサイトの掲載日 ： 令和３年１０月１日 〔刊行物等〕 ウェブサイトのアドレス：ｈｔｈｔｔｐｓ：／／ｗｅｂ－ｍｉｈｏｎｉｃｈｉ．ｔｏｋｙｏ／ｃｏｍｐａｎｙ／ｎａｔｕｒａｌ－ａｂ／ｉｎｄｅｘ． ウェブサイトの掲載日 ： 令和３年５月１７日 〔刊行物等〕 ウェブサイトのアドレス：ｈｔｔｐｓ：／／ｓｐａｏｒｅ．ｃｏｍ／ ｈｔｔｐｓ：／／ｗｗｗ．ｓａｎｋｅｉｂｉｚ．ｊｐ／ｂｕｓｉｎｅｓｓ／ｎｅｗｓ／２１０８０４／ｐｒｌ２１０８０４０９３３０１０－ｎ１．ｈｔｍ ウェブサイトの掲載日 ： 令和３年８月１日 〔刊行物等〕 ウェブサイトのアドレス：ｈｔｔｐｓ：／／ｗｗｗ．ｉｄｏｇ．ｊｐ／ｂｌｏｇ／２０２１／１０／２１／ｉｄｏｇｗｅｌｌｎｅｓｗｅａｒ／ ウェブサイトの掲載日 ： 令和３年１０月２１日 〔刊行物等〕 発行者名：株式会社主婦と生活社 刊行物名：疲れとり「極」ミラクルシート 頒布日 ：令和３年４月１５日 （発行日 令和３年４月３０日）Article 30, Paragraph 2 of the Patent Act applies Website address: https://camp-fire. jp/projects/view/344468 Website publication date: January 5, 2021 [Publications, etc.] Website address: https://naturalab. theshop. jp/ https://naturalab. theshop. jp/categories/3225060 Website publication date: January 8, 2021 [Publications, etc.] Website address: https://benechan. shop/tky95851-002/ Website publication date: March 24, 2021 [Publications, etc.] Website address: https://www. amazon. co. jp/Spaol Blood flow improvement Haramaki (Spaol) - Gray/dp/B091PJ3YKY Website publication date: April 1, 2021 [Publications, etc.] Website address: https://alles-inc. com/spaore/ Website publication date: October 1, 2021 [Publications, etc.] Website address: https://web-mihonichi. tokyo/company/natural-ab/index. Website publication date: May 17, 2021 [Publications, etc.] Website address: https://spaore. com/ https://www. sankeibiz. jp/business/news/210804/prl2108040933010-n1. htm Website publication date: August 1, 2021 [Publications, etc.] Website address: https://www. idog. jp/blog/2021/10/21/idogwellneswear/ Website publication date: October 21, 2021 [Publications, etc.] Publisher name: Shufu to Seikatsusha Co., Ltd. Publication name: Tigetori “Kiwami” Miracle Sheet Distribution date: April 15, 2021 (Issuance date: April 30, 2021)
本発明は、血流促進、リラクゼーション及び運動能力向上の作用を有する粉体組成物に関し、より詳細には、腹まき、枕カバー、靴用インソール、シャツ、アクセサリー等、様々な物品に印刷等の手段によって適用できることより、形状や材質を問わず広範囲の物品が作成可能であり、適用後の当該物品に接近する者に対して血流促進、リラクゼーション及び運動能力向上の効果を付与することができる粉体組成物に関する。 The present invention relates to a powder composition that has the effect of promoting blood flow, relaxation, and improving athletic performance, and more particularly, it relates to a powder composition that can be printed on various articles such as belly wraps, pillow cases, shoe insoles, shirts, and accessories. Since it can be applied by any means, it is possible to create a wide range of articles regardless of shape or material, and it can provide the effects of promoting blood flow, relaxation, and improving athletic performance to those who approach the article after application. The present invention relates to a powder composition.
体の冷えや自律神経の乱れは、健康面で様々な不調を引き起こす原因となることが知られている。体の冷えが生じる一因としては血行不良がある。身体の血流が悪くなることで手足の末端まで血液が十分に循環されない状態となり、いわゆる「冷え性」が慢性化した状態となる。これにより、「体が温まり難い」「布団に入っても手足が冷たく眠れない」といった、いわゆる「冷え性」の症状を生じるばかりでなく、代謝が悪化することで更に種々の不調を生じることとなる。具体的には、肩のコリや痛み、頭痛、不眠、生理不順等、様々な症状に悩まさるといった症状が現れたり、また、代謝が落ちることで痩せ難い体質となり肥満に繋がり易い、便秘気味になって肌が荒れる等の美容面での悪影響を及ぼす場合もある。更に、免疫力が低下することにより、風邪などの病気にかかり易い体質となってしまうおそれすらもある。 It is known that a cold body and disturbances in the autonomic nervous system can cause various health problems. Poor blood circulation is one reason why your body feels cold. Due to poor blood flow in the body, blood is not sufficiently circulated to the extremities of the limbs, resulting in a chronic condition called ``sensitivity to cold.'' This not only causes symptoms of so-called ``cold sensitivity'' such as ``difficulty keeping the body warm'' and ``unable to sleep because the hands and feet are cold even when in bed,'' but it also worsens the metabolism, leading to various other problems. . Specifically, symptoms such as shoulder stiffness and pain, headaches, insomnia, irregular menstruation, etc. may appear, and the metabolism may slow down, making it difficult to lose weight, which can easily lead to obesity and constipation. It may also have an adverse effect on beauty, such as skin irritation. Furthermore, there is even a risk that a person's immune system will be weakened, making him or her more susceptible to illnesses such as colds.
また、自律神経は、体を活発に動かすときに働く交感神経と、体を休めるときやリラックスした状態で働く副交感神経で成り立っている。この２つのバランスが崩れた場合、だるい、眠れない、疲れが取れない等の症状が現れ易くなる。また、自律神経が乱れると各個人の弱い部分に不調が現れ易いと言われており、頭痛やめまい、息切れ、動悸、下痢、便秘、冷え等に繋がることもある。更に、自律神経の乱れは、精神面への影響も大きく、情緒不安定や鬱等の症状の原因となることもある。 Furthermore, the autonomic nervous system is made up of the sympathetic nervous system, which works when the body is active, and the parasympathetic nervous system, which works when the body is resting or in a relaxed state. If the balance between these two is disrupted, symptoms such as feeling sluggish, unable to sleep, and unable to relieve fatigue are likely to appear. Furthermore, it is said that when the autonomic nervous system is disrupted, symptoms tend to appear in the weak areas of each individual, which can lead to headaches, dizziness, shortness of breath, palpitations, diarrhea, constipation, coldness, etc. Furthermore, disturbances in the autonomic nervous system have a significant impact on the mental health, and may cause symptoms such as emotional instability and depression.
このように、血行不良や自律神経の乱れは、身体面や精神面での様々の不調の原因となるため、血流を改善し血行をよくする効果や自律神経を整えるべく、様々な方法や器具・装置等がこれまで提案されてきた。例えば、微量の放射線による「ホルミシス効果」を利用したものも多数提案されている。一例をあげると「ホルミシス効果」に注目した遠赤外線照射装置がある（特許文献１参照）。これは、ラジウム粉末またはブラックシリカ粉末のうち少なくとも一方と、炭粉末をそれぞれ所定量混入した岩盤浴クッション芯材とその底面側に配した発熱体より構成される岩盤浴マットユニットの上に人体が横たわり、更に頭部以外の身体を覆部ですっぽりと覆うことで、微弱な放射線によって生成されるマイナスイオン及び遠赤外線を利用者に放射し、いわゆる岩盤浴効果により、温熱効果、新陳代謝、自然治癒力の向上、ストレス改善等の効果を有するとされるものである。 In this way, poor blood circulation and disturbances in the autonomic nervous system can cause a variety of physical and mental disorders, so there are various methods and techniques that can be used to improve blood circulation, improve blood circulation, and adjust the autonomic nervous system. Instruments, devices, etc. have been proposed so far. For example, many methods have been proposed that utilize the ``hormesis effect'' caused by small amounts of radiation. One example is a far-infrared irradiation device that focuses on the "hormesis effect" (see Patent Document 1). The human body is placed on a bedrock bath mat unit consisting of a bedrock bath cushion core material mixed with a predetermined amount of at least one of radium powder or black silica powder and charcoal powder, and a heating element placed on the bottom side of the bedrock bath cushion core material. By lying down and completely covering the body except for the head, negative ions and far infrared rays generated by weak radiation are emitted to the user, and the so-called rock bath effect has a thermal effect, metabolism, and natural healing. It is said to have effects such as improving strength and relieving stress.
しかし、当該装置は、人体が横たわるに足るスペースが必要であり、それなりに大型な装置となることは避けられない。また、いわゆる岩盤浴であるため、効果を得るためには一定時間の間、そこに留まり続けることが必要であり、日常生活に気楽に取り込むのは難しい側面もあった。また、体の冷えや自律神経の乱れによる不調は、数回の処置によって全快するということは少ないため、これらの症状に悩まされる人にとっては、日常的に気楽に使用できる物や方法で健康を維持できるのであれば、その方が望ましいことは言うまでもない。本発明は、このような実情を鑑み、どのような物品にも応用が容易である粉体形状となっている。粉体であることから種々の物品への適用が極めて容易であり、使用者が普段から日常的に使用や着用している物品へも容易に適用することができる。このため、使用者は使用していることすらほとんど意識することなく、本発明の粉体組成物を日常生活に取り込むことが可能である。このように、本発明は、使用が極めて容易でありながら、確実に血行促進や自律神経を整える効果を有する血流促進及びリラクゼーションのための粉体組成物を提供するものである。 However, this device requires enough space for a human body to lie down, and it is inevitable that the device will be relatively large. Furthermore, since it is a so-called bedrock bath, it is necessary to remain there for a certain period of time in order to obtain the effects, making it difficult to incorporate it into daily life. In addition, it is rare for ailments caused by body cold or autonomic nervous system disturbances to be completely cured with just a few treatments, so people who suffer from these symptoms may want to improve their health with products and methods that they can easily use on a daily basis. Needless to say, it is preferable if it can be maintained. In view of these circumstances, the present invention has a powder form that can be easily applied to any article. Since it is a powder, it is extremely easy to apply to various articles, and it can also be easily applied to articles that users use or wear on a daily basis. Therefore, it is possible for the user to incorporate the powder composition of the present invention into his or her daily life without even being aware that he or she is using it. As described above, the present invention provides a powder composition for blood flow promotion and relaxation that is extremely easy to use and has the effect of reliably promoting blood circulation and regulating autonomic nerves.
本発明者は、「ホルミシス効果」により身体の重心を安定させることで、つまずき等の外的内的要因による転倒等を防止する効果を有する、微粉末状のラジウムと微粉末状の炭粉とを含有した粉体組成物を提案している（特許第６８０２９４０号公報）。
本発明者が鋭意検討を続けた結果、当該粉体組成物は、ラジウムと炭粉が特定の組成比率であるときに、特に神経コンディショニング効果を発揮することによって、血流促進作用や自律神経のバランスを整える作用が極めて優れていることを見出した。更に、この「神経のコンディションを整える」作用によって、身体パフォーマンスの向上等の運動能力向上の作用をも有していることを見出し、本発明の「血流促進、リラクゼーション及び運動能力向上のための粉体組成物」（以下、これらを総称する意において「本発明の粉体組成物」と称する）を完成するに至ったものである。
The present inventor has discovered that finely powdered radium and finely powdered charcoal powder have the effect of stabilizing the body's center of gravity through the "hormesis effect," thereby preventing falls caused by external and internal factors such as stumbling. has proposed a powder composition containing (Japanese Patent No. 6802940).
As a result of intensive studies by the present inventors, the powder composition has been found to have a particularly nerve conditioning effect when radium and charcoal powder are in a specific composition ratio, thereby promoting blood flow and stimulating autonomic nerves. We have discovered that it has an extremely good effect on regulating balance. Furthermore, it was discovered that this action of "adjusting the condition of the nerves" also has the effect of improving athletic ability such as improving physical performance, and the present invention's "promoting blood flow, relaxation, and improving athletic ability" Powder composition" (hereinafter collectively referred to as "powder composition of the present invention") was completed.
上記課題を解決するために、本発明の粉体組成物は、微粉末状のラジウム１重量部に対して、微粉末状の炭化粉を４．５～５０重量部の割合で含有することを特徴としている。 In order to solve the above problems, the powder composition of the present invention contains 4.5 to 50 parts by weight of finely powdered carbonized powder per 1 part by weight of finely powdered radium. It is a feature.
ここで、炭化粉は３０～９７％の割合でケイ素を含有してもよく、天然植物材料を炭化することで得られるものであってもよい。 Here, the carbonized powder may contain silicon in a proportion of 30 to 97%, and may be obtained by carbonizing natural plant materials.
また、本発明の粉体組成物は、更に、微粉末状のゲルマニウムおよび微粉末状の銅の少なくとも１つを含有してもよい。 Further, the powder composition of the present invention may further contain at least one of finely powdered germanium and finely powdered copper.
そして、本発明の粉体組成物の製造方法は、ラジウムを含有する鉱石を破砕して微粉末状の粉砕物を作成すると共に、天然植物材料を温度７００～１５００℃で１～５時間加熱して得た炭化物を粉砕することにより微粉末状の炭化粉を作成し、前記粉砕物と炭化粉とを混合することにより粉体組成物を作成することを特徴としている。 The method for producing the powder composition of the present invention includes crushing radium-containing ore to create a finely ground product, and heating natural plant materials at a temperature of 700 to 1500°C for 1 to 5 hours. The method is characterized in that a finely powdered carbonized powder is created by pulverizing the obtained carbide, and a powder composition is created by mixing the pulverized material and the carbonized powder.
また、本発明の粉体組成物を含有することを特徴とするインキまたは塗料として使用することができ、繊維状、布状または板状基材に、本発明の粉体組成物を含有するインキまたは塗料を塗布もしくは含浸させたことを特徴とする繊維、布または板材として使用することができる。 Furthermore, it can be used as an ink or paint characterized by containing the powder composition of the present invention, and the ink containing the powder composition of the present invention can be applied to a fibrous, cloth-like or plate-like substrate. Alternatively, it can be used as fiber, cloth, or board material coated with or impregnated with paint.
本発明の粉体組成物は、粉体形状であることにより、広く種々の物品に適用することができる。具体的には、本発明の粉体組成物を、例えばインキや塗料に配合し印刷手段を介して物品に適用することにより、多種多様な種々の物品へ優れた「血流促進、リラクゼーション及び運動能力向上」の効果を付与することができる。一例を挙げれば、日常的に身に付ける物品である、腹まき、肩掛け、枕用シート、靴のインソール、アイマスクや、肩こり部分や冷え易い部位に貼付するパッチ、更には首から掛けたり胸に付けるＩＤカードのケースに入る大きさのシート等、の種々の物品に本発明の粉体組成物を適用することで、血流促進による冷えの防止、リラクゼーション効果による心身のリラックス効果、運動能力向上効果によるスポーツのパフォーマンス成績の向上の効果を手軽に得ることが可能となる。 Since the powder composition of the present invention is in powder form, it can be applied to a wide variety of articles. Specifically, by blending the powder composition of the present invention with, for example, ink or paint and applying it to articles via printing means, it can be applied to a wide variety of articles to provide excellent "blood flow promotion, relaxation, and exercise". It is possible to give the effect of "ability improvement". For example, items worn on a daily basis such as belly wraps, shoulder blankets, pillow sheets, shoe insoles, eye masks, patches attached to stiff shoulders or areas that get cold easily, and even items worn around the neck or chest. By applying the powder composition of the present invention to various articles such as sheets that are large enough to fit in the case of an ID card attached to a person's body, the powder composition of the present invention can prevent coldness by promoting blood flow, have a relaxing effect on the mind and body through a relaxation effect, and improve athletic performance. It becomes possible to easily obtain the effect of improving sports performance results due to the improvement effect.
物品への適用は、例えば、本発明の粉体組成物を含有させたインキ等を印刷技術を介して物品に付与することで適用することができる。このため、岩盤浴装置のような大掛かりな装置等を製造するのに比較して、大幅に安価な製造コストで本発明の粉体組成物を適用した物品を製作することが可能である。また、腹まきや肩掛けを始めとする使用者が日常的に使用している物品に対して手軽に適用が可能であるため、使用者自身が普段から使用している物品に適用すれば、当該物品をいつも通りに身に着けていつも通りの日常生活を送るだけで、冷えの防止、心身のリラックスや運動能力の向上の効果が得られるメリットがある。 The powder composition of the present invention can be applied to articles by, for example, applying ink containing the powder composition of the present invention to articles through printing technology. Therefore, it is possible to manufacture articles to which the powder composition of the present invention is applied at significantly lower manufacturing costs than manufacturing large-scale equipment such as rock bath equipment. In addition, it can be easily applied to items that users use on a daily basis, such as belly wraps and shoulder bags. Simply wearing the items you normally wear and going about your daily life as usual has the benefit of preventing you from getting cold, relaxing your mind and body, and improving your athletic ability.
また、安価に適用できることから、一つの物品に対して様々なデザインをラインアップすることも比較的容易である。市場において特定のデザインのものしか入手できない場合、当該デザインが個人的嗜好に合わず身に付けることを躊躇してしまうといったことが起こり得る。しかし、製造が比較的安価かつ容易であれば、各人それぞれの好みに合わせた多様なデザインのものをラインアップすることができ、利用者の選択の幅を広げることができる。 Moreover, since it can be applied at low cost, it is relatively easy to line up various designs for one article. If only certain designs are available on the market, it may happen that the design does not suit one's personal taste and people hesitate to wear it. However, if manufacturing is relatively cheap and easy, it is possible to offer a lineup of products with a variety of designs that suit the tastes of each person, thereby widening the range of choices available to users.
本発明の粉体組成物の物品への付与について具体的な一例を挙げれば、例えば腹まきの場合には、シルクで作成した腹まきに印刷を介して本願発明の粉体組成物を適用（付加）して、当該腹まきに「血流促進、リラクゼーション及び運動能力向上」効果を付与することができる。品への適用は、必ずしも物品全体に均一に付加する必要はなく、図１に示すようなドットパターンの他、文字や画像等、ある程度の面積を持って適用すれば十分であるためデザインに対する自由度も比較的高い。また、本願発明の粉体組成物を予め繊維に練り込み、当該繊維を用いて紡織することで繊維製品とすることもできる。このような方法によれば、更にデザインに対する自由度を高めることも可能である。 To give a specific example of applying the powder composition of the present invention to an article, for example, in the case of a belly wrap, the powder composition of the present invention is applied to a belly wrap made of silk through printing ( In addition, it is possible to impart the effect of "promoting blood flow, relaxation, and improving athletic performance" to the belly wrap. Application to products does not necessarily have to be applied uniformly to the entire product; in addition to the dot pattern shown in Figure 1, it is sufficient to apply it to a certain area such as letters and images, so there is freedom in design. The degree is also relatively high. Furthermore, a textile product can be obtained by kneading the powder composition of the present invention into fibers in advance and spinning the fibers using the fibers. According to such a method, it is also possible to further increase the degree of freedom in design.
また、本願発明の粉体組成物は、身体に接触させずともある程度まで接近させることで「血流促進、リラクゼーション及び運動能力向上」の効果が期待できる。このため、身体に直接触れる物品に限らず、衣服の上に身に付けるＩＤカードケースやアクセサリーといった物品に適用して利用することも可能である。この効果により、適用する物品の選択肢が広がるため、利用者が一番利用し易い物品に適用することで、物品の存在を意識することなく冷え防止やリラックス効果を得ることが期待できるものである。 Further, the powder composition of the present invention can be expected to have the effect of "promoting blood flow, relaxation, and improving athletic performance" by bringing it close to the body to a certain extent without contacting it. Therefore, the present invention can be applied not only to articles that come in direct contact with the body, but also to articles such as ID card cases and accessories that are worn over clothes. This effect expands the choice of items to which it can be applied, so by applying it to the items that are most easily used by the user, it can be expected to prevent coldness and obtain relaxing effects without the user being aware of the item's existence. .
本発明の粉体組成物は、微粉末状のラジウム１重量部に対して微粉末状の炭化粉を４．５～５０重量部の割合で含有するものである。当該比率で微粉末状のラジウムと微粉末状の炭化粉を配合することで、粉末状態としても、天然鉱石の発する微弱電磁波の効果と炭化粉による放射熱効果の両方を極めて効果的に発揮し、更に、神経コンディショニング効果も同時に発揮することで、優れた「血流促進、リラクゼーション及び運動能力向上」効果を発揮するものである。 The powder composition of the present invention contains 4.5 to 50 parts by weight of finely powdered carbonized powder per 1 part by weight of finely powdered radium. By blending finely powdered radium and finely powdered carbonized powder in this ratio, even in powdered form, it can extremely effectively exert both the effect of weak electromagnetic waves emitted by natural ores and the radiant heat effect of carbonized powder. Furthermore, by simultaneously exerting a nerve conditioning effect, it exhibits an excellent effect of "promoting blood flow, improving relaxation, and improving athletic performance."
ここで「神経コンディショニング」とは、神経のコンディションを整える作用のことであり、「神経のコンディションが整う」とは、神経線維に興奮部が存在することで電位配列が乱れ電流（命令）の流れが阻害されているときに、何らかの働きかけにより正常な電位配列に戻った状態を指すものである。電流（命令）の流れがスムーズな状態に戻ることで、阻害されていた神経の命令伝達が末梢神経まで届くことになる。この働きにより、身体の重心バランスが安定し、更に高い効果を発揮する場合には運動パフォーマンスの向上といった運動能力向上効果となって現れることになる。また、神経の乱れによるストレスが軽減されることにより、副交感神経優位にスイッチし易い状態になって心身のリラクゼーション効果を得ることができる。本願発明の粉体組成物では、これらの働きに加えて、前述の天然鉱石の発する微弱電磁波の効果と炭化粉による放射熱効果も同時に発揮されることとなる。天然鉱石の発する微弱電磁波によってリラクゼーション効果は更に増大される。また、炭化粉による放射熱効果によって血行促進作用が得られる。血行が促進されて血流が良くなることで身体が温まり、よりリラックスし易い状態になるという相乗効果を発揮するものである。 Here, "nerve conditioning" refers to the action of adjusting the condition of the nerves, and "conditioning the nerves" means that the presence of excitatory parts in nerve fibers disrupts the potential arrangement and the flow of current (commands). This refers to the state in which the normal potential arrangement is restored by some action when the voltage is inhibited. By restoring the flow of current (commands) to a smooth state, the blocked nerve command transmission can now reach the peripheral nerves. This function stabilizes the balance of the body's center of gravity, and in cases where even greater effects are achieved, this will manifest itself in the effect of improving athletic ability, such as improving athletic performance. Furthermore, by reducing the stress caused by disturbances in the nervous system, the parasympathetic nervous system can easily switch to the dominant state, resulting in a relaxing effect on the mind and body. In addition to these functions, the powder composition of the present invention simultaneously exhibits the effect of the weak electromagnetic waves emitted by the natural ore and the radiant heat effect of the carbonized powder. The relaxation effect is further enhanced by the weak electromagnetic waves emitted by natural ores. Additionally, the radiant heat effect of the carbonized powder can promote blood circulation. This has a synergistic effect in that blood circulation is promoted and the blood flow improves, which warms the body and makes it easier to relax.
次に、本願発明の粉体組成物について詳述する。
本願発明の粉体組成物は、微粉末状ラジウムと微粉末状の炭粉の他に、更に、微粉末状のゲルマニウムおよび微粉末状の銅の少なくとも１つを含有させることができる。以下、それらの微粉末状物について具体例を示して説明するが、本発明に用いることができる物がそれらに限定されるものではない。
Next, the powder composition of the present invention will be explained in detail.
The powder composition of the present invention can further contain at least one of finely powdered germanium and finely powdered copper in addition to finely powdered radium and finely powdered charcoal powder. Specific examples of these fine powders will be explained below, but the products that can be used in the present invention are not limited thereto.
本発明における微粉末状のラジウムとは、ラジウムを含む化合物、例えば、酸化ラジウム、水酸化ラジウム、フッ化ラジウム、塩化ラジウム、臭化ラジウム、ヨウ化ラジウム、炭酸ラジウム、硫酸ラジウム、硫化ラジウム、過酸化ラジウム等のラジウム化合物の他、ラジウムを含有する天然鉱石を原料として、これらの物質を公知の方法で微粉末状にしたものをいう。 In the present invention, finely powdered radium refers to compounds containing radium, such as radium oxide, radium hydroxide, radium fluoride, radium chloride, radium bromide, radium iodide, radium carbonate, radium sulfate, radium sulfide, and In addition to radium compounds such as radium oxide, natural ores containing radium are used as raw materials, and these substances are made into fine powder by a known method.
本発明における微粉末状のゲルマニウムとは、ゲルマニウムを含む化合物、例えば、二酸化ゲルマニウム、水酸化ゲルマニウム、ゲルマニウムテトラメトキシド、ゲルマニウムテトラエトキシド、ゲルマニウムテトラブトキシド、ゲルマニウムエチレングリコキシド等のゲルマニウムアルコキシド化合物、ゲルマニウムフェノレート、ゲルマニウム－β－ナフトレート等のゲルマニウムフェノキシド化合物、リン酸ゲルマニウム、亜リン酸ゲルマニウム、次亜リン酸ゲルマニウム等のリン含有ゲルマニウム化合物および酢酸ゲルマニウム化合物等のゲルマニウムを含む化合物の他、ゲルマニウムを含有する天然鉱石や天然鉱物を原料として、これらの物質を公知の方法で微粉末状にしたものをいう。 In the present invention, finely powdered germanium refers to compounds containing germanium, such as germanium alkoxide compounds such as germanium dioxide, germanium hydroxide, germanium tetramethoxide, germanium tetraethoxide, germanium tetrabutoxide, and germanium ethylene glycoxide; In addition to germanium-containing compounds such as germanium phenoxide compounds such as phenolate and germanium-β-naphthlate, phosphorus-containing germanium compounds such as germanium phosphate, germanium phosphite, and germanium hypophosphite, and germanium acetate compounds, germanium-containing compounds These substances are made into fine powder using known methods, using natural ores and natural minerals as raw materials.
本発明における微粉末状の銅とは、銅を含む化合物、例えば、酸化第一銅、酸化第二銅、塩化第一銅、塩化第二銅、硫化第一銅、硫化第二銅、酢酸第一銅、酢酸第二銅、硫酸第一銅、硫酸第二銅等の銅化合物の他、精製銅や銅鉱物を原料として、これらの物質を公知の方法で微粉末状にしたものをいう。なお、以上のゲルマニウム、ラジウム、銅の各化合物については、水溶液等の液状態のものを以下に述べる炭粉に含浸させてもよい。 Finely powdered copper in the present invention refers to compounds containing copper, such as cuprous oxide, cupric oxide, cuprous chloride, cupric chloride, cuprous sulfide, cupric sulfide, and cuprous acetate. In addition to copper compounds such as copper, cupric acetate, cuprous sulfate, cupric sulfate, etc., refined copper and copper minerals are used as raw materials, and these substances are made into fine powder by a known method. Note that the above-mentioned germanium, radium, and copper compounds may be impregnated with a liquid state such as an aqueous solution into the charcoal powder described below.
本発明における微粉末状の炭化粉とは、炭素を含有する物質を微粉末状にしたものを用いることができる。微粉末状の炭化粉の原材料としては、グラファイトや石墨、黒鉛等の結晶質物質であってもよいが、非晶質物質である植物材料を焼成して作成したいわゆる炭を特に好適に用いることができる。炭の場合には、木炭や竹炭等の他、ヤシ殻、石炭、木炭等を原料とした活性炭等、炭素を含有するものであればどのようなものも用いることができる。炭を用いる場合には、自身で焼成した炭を微粉末状にしたものであってもよいし、粉末の炭（パウダー状の炭）、炭の粉、木炭微粉、粉炭、炭パウダー等の種々の名称で市販されているものを用いてもよい。 The carbonized powder in the form of a fine powder in the present invention may be a substance containing carbon that is made into a fine powder. As a raw material for the finely powdered carbonized powder, crystalline substances such as graphite, graphite, and graphite may be used, but so-called charcoal, which is created by firing plant materials that are amorphous substances, is particularly preferably used. Can be done. In the case of charcoal, any carbon-containing material can be used, such as charcoal, bamboo charcoal, activated carbon made from coconut shell, coal, charcoal, etc. When using charcoal, it may be charcoal that has been burnt by itself and made into a fine powder, or it may be charcoal that has been fired by itself, or various types such as powdered charcoal (powdered charcoal), charcoal powder, charcoal fine powder, pulverized charcoal, charcoal powder, etc. You may use what is commercially available under the name.
本発明における微粉末状の炭粉は、ケイ素を含むものを特に好ましく用いることができる。上記の結晶質炭素を粉末にしたものに、ケイ素化合物の粉末を混合したものであってもよいが、天然の植物材料を炭化させた炭を原料として作成した炭粉には植物由来のケイ素が含まれるため極めて好適に用いることができる。ケイ素化合物を用いる場合には、シリカ（二酸化ケイ素）、合成非晶質シリカ（二酸化ケイ素）、ケイ酸アルミニウム、ケイ酸マグネシウム、ケイ酸カルシウム、ケイ酸ジルコニウム、炭化ケイ素、ケイ藻土等のケイ素含有化合物を広く用いることができる。天然の植物材料を炭化させたものとしては、安価に広く流通しているもみ殻くん炭やその他のくん炭を用いることもできるし、自ら木材、竹、もみ殻等の植物材料を焼成した炭やくん炭を用いてもよい。 As the finely powdered charcoal powder in the present invention, one containing silicon can be particularly preferably used. The above-mentioned crystalline carbon powder may be mixed with silicon compound powder, but charcoal powder made from charcoal made from carbonized natural plant materials contains plant-derived silicon. Therefore, it can be used very suitably. When using silicon compounds, silicon-containing materials such as silica (silicon dioxide), synthetic amorphous silica (silicon dioxide), aluminum silicate, magnesium silicate, calcium silicate, zirconium silicate, silicon carbide, diatomaceous earth, etc. A wide variety of compounds can be used. As for carbonized natural plant materials, you can use rice husk charcoal or other types of charcoal, which are widely distributed at low prices, or you can use charcoal made from wood, bamboo, rice husk, or other plant materials. Yakun charcoal may also be used.
自ら、もみ殻等の植物材料を焼成して炭やくん炭を作る場合には、植物材料を高温短時間で焼成したものを特に好ましく用いることができる。焼成条件は、７００～１５００℃で１～５時間、特に好ましくは８００～１２００℃で２～４時間の焼成が望ましい。焼成時には、焼成開始時からできるだけ早く８００～１２００℃の焼成温度にまで到達させることが望ましく、例えば焼成炉の電圧を一気に上げて焼成開始時から３０～６０分で焼成温度に到達させて焼成させることでケイ素含有量を高めることができる点で特に望ましい。微粒子状のラジウムに、このように高温短時間で焼成した炭やくん炭から作成されるケイ素含有率の高い炭粉を混合することで、特に好ましい本願発明の粉体組成物とすることができる。 When making charcoal or charcoal by burning plant materials such as rice husks, it is particularly preferable to use plant materials that have been baked at high temperatures and for short periods of time. The firing conditions are preferably 700 to 1500°C for 1 to 5 hours, particularly preferably 800 to 1200°C for 2 to 4 hours. During firing, it is desirable to reach a firing temperature of 800 to 1200°C as soon as possible from the start of firing, for example, by increasing the voltage of the firing furnace all at once and firing by reaching the firing temperature in 30 to 60 minutes from the start of firing. This is particularly desirable in that it can increase the silicon content. A particularly preferable powder composition of the present invention can be obtained by mixing fine particle radium with charcoal powder having a high silicon content made from charcoal or charcoal fired at high temperatures and short times. .
本願発明に用いる微粉末状物質を作成する方法としては、上記のそれぞれの化合物を、例えばミルと分級機を用いて粉砕し微粉末状にする等の公知の方法を用いることができる。粉砕後の粒径は特に限定されず、用途に合わせて粗くしてもよいし、微細粉としてもよい。扱い易さの点で、粒径は3μｍ～0.1ｍｍが好ましく、5μｍ～7μｍが特に好ましい。 As a method for producing the finely powdered substance used in the present invention, a known method such as pulverizing each of the above-mentioned compounds using a mill and a classifier to form a fine powder can be used. The particle size after pulverization is not particularly limited, and may be coarse or fine depending on the purpose. In terms of ease of handling, the particle size is preferably 3 μm to 0.1 mm, particularly preferably 5 μm to 7 μm.
微粉末状にしたそれぞれの化合物を混合する方法は、特に限定されない。ある程度まで均一に混合されていれば本発明の効果を得るのに十分であるので、公知の一般的な方法にて混合することができる。本発明の粉体組成物における各成分の混合比は、ラジウム１重量部に対して微粉末状の炭粉を４．５～５０重量部加えて混合したものが本発明の有意な効果を得るために好ましく、特に好ましくはラジウム１重量部に対して微粉末状の炭粉を５～２０重量部加えて混合したものが顕著な効果を得るために好ましい。更に、微粉末状のゲルマニウムもしくは微粉末状の銅を混合する場合には、それぞれ重量比でラジウム１重量部に対して微粉末状のゲルマニウムもしくは微粉末状の銅をそれぞれ０．１～５重量部加えることができる。微粉末状のゲルマニウムもしくは微粉末状の銅を更に加えることで、効果を補強することができると共にラジウムの使用量を減量することができる。微粉末状のゲルマニウムもしくは微粉末状の銅は、それぞれどちらか一方を加えることもできるし、両方をそれぞれ上記の比率で加えることもできる。 The method of mixing the respective finely powdered compounds is not particularly limited. Since it is sufficient to obtain the effects of the present invention if the components are mixed uniformly to a certain extent, they can be mixed using a known general method. The mixing ratio of each component in the powder composition of the present invention is such that 4.5 to 50 parts by weight of finely powdered charcoal powder is added to 1 part by weight of radium to obtain the significant effects of the present invention. For this reason, it is particularly preferable to mix 5 to 20 parts by weight of finely powdered charcoal powder to 1 part by weight of radium in order to obtain a remarkable effect. Furthermore, when mixing finely powdered germanium or finely powdered copper, the weight ratio of finely powdered germanium or finely powdered copper is 0.1 to 5 parts by weight, respectively, to 1 part by weight of radium. can be added. By further adding finely powdered germanium or finely powdered copper, the effect can be reinforced and the amount of radium used can be reduced. Either one of finely powdered germanium or finely powdered copper can be added, or both can be added in the above-mentioned ratio.
本発明の粉体組成物は、次のような方法で使用することができる。たとえば、本発明の粉体組成物をそのまま容器等に入れてそれを身に付ける等の手段により身体に接近させることで、血流促進、リラクゼーション及び運動能力向上の効果を得ることができる。他の方法としては、例えば本発明の粉体組成物をインキや塗料に混合させ、当該インキや塗料を用いて目的物品に印刷あるいは塗布をする方法がある。このように本発明の粉体組成物を適用させた物品に対して、身体を接近させることで本発明の「血流促進、リラクゼーション及び運動能力向上」の効果を得ることができる。 The powder composition of the present invention can be used in the following methods. For example, by placing the powder composition of the present invention in a container or the like and bringing it close to the body by wearing it, the effects of promoting blood flow, relaxation, and improving athletic performance can be obtained. Other methods include, for example, mixing the powder composition of the present invention with ink or paint and printing or coating the target article using the ink or paint. By bringing one's body close to an article to which the powder composition of the present invention has been applied in this way, the effects of "promoting blood flow, improving relaxation, and improving athletic performance" of the present invention can be obtained.
また、本発明の粉体組成物は、例えば液体に分散させて流体形態としてもよいし、公知の方法により固化させて固形状としてもよい。どのような形態へ加工しても本発明の有する「血流促進、リラクゼーション及び運動能力向上」の効果が失われることはないため、使用目的や流通の利便性等により適宜最適な形態での使用が可能である。 Further, the powder composition of the present invention may be made into a fluid form by dispersing it in a liquid, for example, or may be made into a solid form by solidifying it by a known method. No matter what form it is processed into, the effects of "promoting blood flow, promoting relaxation, and improving athletic performance" of the present invention will not be lost, so it can be used in the form that is most appropriate depending on the purpose of use, convenience of distribution, etc. is possible.
以下、具体的な使用方法についていくつか詳述するが、本発明はこれらの使用方法や使用形態に限定されず、どのような方法であれ、本発明の粉体組成物に対して身体が接近した状態となるように用いることで本発明の粉体組成物による「血流促進、リラクゼーション及び運動能力向上」の効果を得ることができる。 Hereinafter, some specific usage methods will be described in detail, but the present invention is not limited to these usage methods or usage forms. By using the powder composition of the present invention in such a state, it is possible to obtain the effects of "promotion of blood flow, relaxation, and improvement of athletic performance" by the powder composition of the present invention.
第一の実施形態として、本発明の粉体組成物を含有させたインキや塗料を用いて目的物に付与することで、当該物品に本発明の「血流促進、リラクゼーション及び運動能力向上」の効果を具有させる方法がある。なお、本明細書において、インキ（インク）または塗料とは、一般的な意味でのインキ、塗料の他、塗装材、顔料、染料等を含む幅広い意味で用いるものである。 As a first embodiment, by applying the ink or paint containing the powder composition of the present invention to a target object, the "promoting blood flow, relaxation, and improving athletic performance" of the present invention can be applied to the object. There is a way to make it effective. In addition, in this specification, ink (ink) or paint is used in a wide sense including not only ink and paint in a general sense, but also coating materials, pigments, dyes, and the like.
本発明の粉体組成物は、適用対象である目的物品に、どのような手段であるかを問わず、付着、付加、含有等の方法により、物品に対していわゆる適用された状態とすることで、適用させた物品に接近した身体に対して「血流促進、リラクゼーション及び運動能力向上」効果を示すものである。このため、たとえば、本発明の粉体組成物を、分散、混合、溶解等の公知の方法でインキや塗料等に含有させ、当該インキや塗料等を用いて、印刷、塗布、含浸、表面に接着させる等の公知の手段により目的物品へ適用させることで、「血流促進、リラクゼーション及び運動能力向上」効果を持つ物品を製作することが可能となる。 The powder composition of the present invention can be applied to a target article by any method such as adhesion, addition, inclusion, etc. to the target article. It shows the effect of ``promoting blood flow, relaxation, and improving athletic performance'' on the body that is close to the applied article. For this reason, for example, the powder composition of the present invention may be incorporated into an ink or paint by a known method such as dispersion, mixing, or dissolution, and the ink or paint may be used to print, apply, impregnate, or coat the surface. By applying it to a target article by known means such as adhesion, it is possible to produce an article that has the effects of "promoting blood flow, improving relaxation, and improving athletic performance."
適用方法としては、印刷もしくはそれに類する手段の他、例えば、本発明の粉体組成物を接着剤に分散させて当該接着剤を物品表面に塗布する方法でもよいし、粉体組成物を分散させた水や油等の液体を目的物品に含浸させることで物品に適用する方法であってもよい。本明細書におけるインキまたは塗料とは、このようにどのような方法であるかを問わず、目的物品に粉体組成物を適用するために用いることができる液体や粘性物、個体等を含む広い意味で用いるものである。 As an application method, in addition to printing or similar means, for example, a method of dispersing the powder composition of the present invention in an adhesive and applying the adhesive to the surface of the article, or a method of dispersing the powder composition of the present invention and applying the adhesive to the surface of the article may be used. Alternatively, a method may be used in which the target article is impregnated with a liquid such as water or oil. In this specification, ink or paint refers to a wide range of materials including liquids, viscous materials, solid materials, etc. that can be used to apply a powder composition to a target article, regardless of the method used. It is used in a meaning.
本発明の粉体組成物を含有させたインキや塗料の作成方法は特に限定されず、一般的な方法を用いることができる。どのような方法であれ、本発明の粉体組成物がインキや塗料に含まれた状態となればよい。ある程度均一に、本発明の粉体組成物が分散した状態のインキや塗料であれば、本発明の効果を得ることができる。例えば、通常用いられる印刷用インキに本発明の粉体組成物を加えた後によく撹拌して混合する方法であってもよい。本発明の粉体組成物のインキへの配合量の目安は、印刷により適用した目的物品の１ｍ２あたり粉体組成物１０ｇ以上が含まれるように配合することで、本発明の重心安定効果を有意に得ることができる。 The method for preparing ink or paint containing the powder composition of the present invention is not particularly limited, and a general method can be used. Any method may be used as long as the powder composition of the present invention is included in the ink or paint. The effects of the present invention can be obtained as long as the ink or paint contains the powder composition of the present invention dispersed to some extent uniformly. For example, a method may be employed in which the powder composition of the present invention is added to a commonly used printing ink and then thoroughly stirred and mixed. A rough guideline for the amount of the powder composition of the present invention to be added to the ink is to ensure that the center of gravity stabilizing effect of the present invention is achieved by blending the powder composition in an amount of 10 g or more per 1 m 2 of the target article to which it is applied by printing. can be obtained significantly.
インキや塗料に混ぜることで、布、紙、ゴム、塩ビ、金属板等広い素材に例えば印刷を介して本発明の粉体組成物を適用することが可能となり、多種多様な物品に本発明の血流促進、リラクゼーション及び運動能力向上効果を付与することが可能となる。一例を挙げれば、作成した腹まきの表面に本発明の粉体組成物を含有させたインキを用いて印刷を施すことで、血流促進、リラクゼーション及び運動能力向上の効果を有する腹まきを作成することができる。 By mixing with ink or paint, the powder composition of the present invention can be applied to a wide range of materials such as cloth, paper, rubber, PVC, metal plates, etc., for example, through printing, and the powder composition of the present invention can be applied to a wide variety of articles. It is possible to provide effects of promoting blood flow, relaxation, and improving athletic performance. For example, by printing on the surface of a prepared belly wrap using an ink containing the powder composition of the present invention, a belly wrap that has the effects of promoting blood flow, relaxation, and improving athletic performance can be created. can do.
また、熱転写紙のインキに本発明の粉体組成物を含有させ作成した熱転写シートを用いて、いわゆるアイロンプリントの方法で靴下やシャツ等に本発明の粉体組成物を適用することもできる。このような方法によれば、本発明の「血流促進、リラクゼーション及び運動能力向上」効果が付与された物品を家庭でも手軽に作成可能となる。 Furthermore, the powder composition of the present invention can also be applied to socks, shirts, etc. by a so-called iron-on printing method using a thermal transfer sheet prepared by incorporating the powder composition of the present invention in the ink of the thermal transfer paper. According to such a method, it is possible to easily create an article having the effects of "promoting blood flow, promoting relaxation, and improving athletic performance" of the present invention at home.
本発明の粉体組成物の適用対象は、このように印刷手段によって物品へ適用する場合には、対象物は印刷可能な物であれば、紙、布、不織紙、木材、プラスチック、金属等、どのような材料へも適用可能である。また、印刷を施すのが難しい材料の場合には、本発明の粉体組成物を分散させた適当な接着剤や溶剤を塗布や含浸させる等の手段によって物品へ適用することもできる。また、衣料品の場合には、繊維に本発明の粉体組成物を公知の方法で予め練り込み、当該繊維を用いて衣料品を作成する方法によって適用することも可能である。その他、方法を問わず物品に本発明の粉体組成物を付加、付着、含有した状態とすれば、当該物品に「血流促進、リラクゼーション及び運動能力向上」の作用を付加することが可能である。すなわち、薄くてペラペラした紙状の物質、ある程度の厚みや固さを有する板状基材等、あらゆる素材に対して、本発明の粉体組成物を含有させたインキや塗料等を塗布または含浸させることで、本発明の「血流促進、リラクゼーション及び運動能力向上」効果を有する布や板材等の材料を作成することが可能である。これは、これらの布や板を用いて物品を製作することで、本発明の「血流促進、リラクゼーション及び運動能力向上」効果を有する多種多様な製品を製造できることを意味している。 When the powder composition of the present invention is applied to an article by printing means, the object can be printed on paper, cloth, nonwoven paper, wood, plastic, metal, etc. It can be applied to any material. Furthermore, in the case of materials that are difficult to print on, the powder composition of the present invention can be applied to the article by coating or impregnating with a suitable adhesive or solvent in which the powder composition is dispersed. Furthermore, in the case of clothing, the powder composition of the present invention can be kneaded into fibers in advance by a known method, and the powder composition can be applied by a method of creating clothing using the fibers. In addition, regardless of the method, if the powder composition of the present invention is added to, adhered to, or contained in an article, it is possible to add effects of "promoting blood flow, relaxation, and improving athletic performance" to the article. be. That is, any material, such as a thin and smooth paper-like substance or a plate-like substrate having a certain degree of thickness and hardness, can be coated or impregnated with an ink or paint containing the powder composition of the present invention. By doing so, it is possible to create materials such as cloth and board materials that have the effects of "promoting blood flow, improving relaxation, and improving athletic performance" of the present invention. This means that by manufacturing articles using these cloths and boards, it is possible to manufacture a wide variety of products that have the effects of "promoting blood flow, improving relaxation, and improving athletic performance" of the present invention.
物品に印刷される形態は特に制限されず、ドットパターンのような繰り返しパターンでもよいし、文字やイラスト等のデザインされたものでもよい。一例として、帆布を用いて作成した靴用インソールの表面に本発明の粉体組成物を、印刷を介して適用した例を図１および２に示した。図１は言語的意味を持たないドットパターンを印刷した例であり、図２は文字を印刷した例である（図２は２枚のインソールを重ねた状態を示したものであり、また、印刷されたＳＰＡＯＲＥの文字は商標である）。ドットパターン、文字のどちらであっても本発明の「血流促進、リラクゼーション及び運動能力向上」効果に違いは生じない。このように、どのような文字や画像であっても本発明の効果に影響はないため、印刷される内容は物品のデザイン性を優先した図柄等であってもよいし、靴下の滑り止めパターンのような実用的なパターン模様等としてもよい。靴下の滑り止めパターンであれば、滑り止め用凹凸の生成材料に本発明の粉体組成物を含有させて凹凸を作成することで、靴下に滑り止め防止効果を付与するのと同時に、本発明の「血流促進、リラクゼーション及び運動能力向上」効果も付与することもできる。 The form printed on the article is not particularly limited, and may be a repeating pattern such as a dot pattern, or a designed form such as letters or illustrations. As an example, FIGS. 1 and 2 show an example in which the powder composition of the present invention was applied to the surface of a shoe insole made of canvas through printing. Figure 1 shows an example in which a dot pattern with no linguistic meaning is printed, and Figure 2 shows an example in which characters are printed (Figure 2 shows two insoles stacked on top of each other; (The letters SPAORE are trademarks.) There is no difference in the effect of "promoting blood flow, relaxation, and improving athletic performance" of the present invention whether it is a dot pattern or letters. In this way, the effect of the present invention is not affected by any type of text or image, so the printed content may be a pattern that prioritizes the design of the article, or a non-slip pattern on socks. It may also be a practical pattern such as. In the case of a non-slip pattern for socks, by incorporating the powder composition of the present invention into the material for generating anti-slip unevenness to create unevenness, the anti-slip effect can be imparted to the socks, and at the same time, the present invention can be applied. ``Blood flow promotion, relaxation, and exercise performance improvement'' effects can also be imparted.
また、第二の使用形態として、本発明の粉体組成物そのものを身につける方法であってもよい。例えば、小瓶のような小さな容器に本発明の粉体組成物を封入し、それをペンダントのようなアクセサリー形態として身につける方法でも本発明の「血流促進、リラクゼーション及び運動能力向上」の効果を得ることができる。 Moreover, as a second usage form, the powder composition of the present invention itself may be worn. For example, a method of enclosing the powder composition of the present invention in a small container such as a vial and wearing it as an accessory such as a pendant can also achieve the effects of "promoting blood flow, improving relaxation, and improving athletic performance" of the present invention. can be obtained.
更に第三の使用形態として、本発明の粉体組成物を添加した成型材料を用いて種々の成型製品を製造することもできる。例えば、本発明の粉体組成物を添加したプラスチック樹脂やラバー樹脂等の合成樹脂を用いて杖やステッキ、ゴルフクラブのグリップ（握り）部分を成型製造することで、「血流促進、リラクゼーション及び運動能力向上」効果を有する杖やステッキ、ゴルフクラブを製造することができる。 Furthermore, as a third usage form, various molded products can be manufactured using the molding material to which the powder composition of the present invention is added. For example, by molding and manufacturing canes, sticks, and grips of golf clubs using synthetic resins such as plastic resins and rubber resins to which the powder composition of the present invention has been added, Canes, walking sticks, and golf clubs that have the effect of "improving athletic performance" can be manufactured.
以下、いくつかの実施例に基づいて本発明の実施態様を具体的に説明するが、本発明はこれに限定されるものではない。 Hereinafter, embodiments of the present invention will be specifically described based on some examples, but the present invention is not limited thereto.
各成分を表１に示した比率（重量部）で混合して、比較例および本発明の実施例の重心安定用粉体組成物を作成した。ラジウムは、ラジウム天然鉱石を粉砕して微粒粉末とした市販品を用いた。炭化粉は、入手した稲のもみ殻を燃焼炉により８００℃で４時間焼成してもみ殻くん炭を作成し、それを粉砕して微粒粉末としたものを用いた。それぞれの微粒粉末の粒径は概ね７μｍとした。 Each component was mixed in the proportions (parts by weight) shown in Table 1 to prepare powder compositions for stabilizing the center of gravity of Comparative Examples and Examples of the present invention. As radium, a commercially available product obtained by crushing natural radium ore into fine powder was used. The carbonized powder used was obtained by burning rice husks in a combustion furnace at 800° C. for 4 hours to create rice husk charcoal, which was then ground into fine powder. The particle size of each fine powder was approximately 7 μm.
試験１－１ ＜簡易バランス試験＞
各成分を表１の比率（重量部）で混合して作成した各サンプル番号の粉体組成物を、インキに混ぜてよく攪拌してインキ中に均等に分散させて印刷用インキとした。尚、サンプルＮｏ．７～１１は、ラジウム１重量部に対して、炭化粉を４．５～５０重量部の割合で混合させた本発明の実施例であり、サンプルＮｏ．１及び２は、ラジウムか炭化粉のいずれか一方のみを含む比較例、サンプルＮｏ．３～６は、ラジウムに対する炭化粉の混合割合を本発明の範囲外とした比較例である。使用したインキは、東京インキ製油性黒色インキを用いた。このようにして作成したインキを用いて図３に示したシートを作成した。具体的には、１０００ｍｍ×６００ｍｍのシート状の帆布２１の表面全面に図３に示したドットパターン２２を印刷し、粉体組成物を適用したシート２とした。尚、粉体組成物のインキへの配合量は、印刷後のシート１ｍ２あたり粉体組成物が概ね１０～２０ｇ含まれるように調整した。
Test 1-1 <Simple balance test>
Powder compositions of each sample number prepared by mixing each component at the ratio (parts by weight) shown in Table 1 were mixed with ink and thoroughly stirred to be uniformly dispersed in the ink to obtain printing ink. In addition, sample No. Sample Nos. 7 to 11 are examples of the present invention in which carbonized powder was mixed at a ratio of 4.5 to 50 parts by weight to 1 part by weight of radium. Sample No. 1 and No. 2 are comparative examples containing only either radium or carbonized powder. Examples 3 to 6 are comparative examples in which the mixing ratio of carbonized powder to radium was outside the range of the present invention. The ink used was Tokyo Ink oil-based black ink. The sheet shown in FIG. 3 was created using the ink thus created. Specifically, a dot pattern 22 shown in FIG. 3 was printed on the entire surface of a sheet-like canvas 21 measuring 1000 mm x 600 mm, to obtain a sheet 2 to which the powder composition was applied. The amount of the powder composition added to the ink was adjusted so that approximately 10 to 20 g of the powder composition was contained per 1 m 2 of the printed sheet.
被験者である成人男女４人に対し、サンプル番号１～１１のうちから無作為に抽出したサンプルを、１被験者あたり５～７つを割り当てた。ただし、サンプル番号１つあたりの被験者は最低２人となるように調整をおこなった。粉体組成物を適用したシート２を約１２ｃｍ×１０ｃｍの大きさにカットし、被験者の服のポケット（上着のサイドポケット）に入れて身に着けてもらう形で以下に示す試験をおこなった。尚、ポケットにシートを入れる際に、被験者に何番のサンプルであるかはもちろん、どのような機能を持つシートであるかの告知は行っていない。
Four adult male and female subjects were randomly selected from
［試験方法］
まず、被験者にはリラックスした状態でベンチに座ってもらい、左腕を真横にまっすぐ伸ばしてもらう。実験者は、被験者の伸ばした左腕をつかんで被験者の左方向へ軽く引っ張る。これにより被験者の身体がわずかに左に傾いた状態となる。その態勢のままで、実験者が被験者の左肩の上に手を置いて上から強く下方向へ被験者の肩を押す（図４のａ－１は押し始めるところを表す）。このとき、被験者が実験者の押す力に負けて体勢が崩れるか否かを見た。実験者の力に負けたときは被験者の上半身は左方向へ大きく傾くことになるが（図４のａ－２の状態）、実験者の押す力に耐えられる場合には被験者の体勢は崩れることがない。次に右側に対しても同様の所作により試験を行う。
[Test method]
First, participants were asked to sit relaxed on a bench and extend their left arm straight out to the side. The experimenter grabbed the subject's outstretched left arm and pulled it slightly to the left of the subject. This caused the subject's body to lean slightly to the left. While maintaining this posture, the experimenter placed his hand on the subject's left shoulder and pushed the subject's shoulder strongly downwards from above (a-1 in Figure 4 represents the point at which the push begins). At this time, we checked to see if the subject would succumb to the experimenter's pushing force and lose his or her posture. When the subject's upper body is defeated by the experimenter's force, the subject's upper body will tilt significantly to the left (state a-2 in Figure 4), but if the subject's pushing force can be withstood, the subject's posture will collapse. There is no. Next, perform the test on the right side using the same movements.
試験は、まずポケットに何も入れない状態で上記の肩を押す一連の動作を行って、被験者がどの程度まで体勢を崩してしまうのかを確認した。その後、リセット動作として、被験者に立ちあがってもらってその場で数回の足踏みをしてもらった。そして次に、再度着席してもらい、サンプルを被験者の上着ポケットに入れて、上記の肩を押す一連の動作を再度同様に行って体勢が崩れるかを見た。そして最後に確認試験として、再び立ち上がってもらって足踏みという上記のリセット動作後に着席してもらってから、ポケットからサンプルを取出して、同様の一連の動作によって被験者の体勢の崩れを確認した。評価は以下の基準により行った。尚、本試験においては被験者によるバラつきは見られず、同一サンプルに対する各被験者は皆ほぼ同じ挙動を示した。
［評価基準］
サンプルをポケットに入れていない場合には、どの被験者も肩を押されることで大きく体勢を崩した。
×：サンプルを入れた場合でも、肩を押されると大きく体勢を崩した。
△：サンプルを入れた場合は、入れない場合に比べて明らかに体勢の崩れが小さかった。
○：サンプルを入れた場合は、肩を押されてもほとんど体勢の崩れが見られなかった。
In the test, the subjects first performed the above-mentioned shoulder-pushing motion without anything in their pockets to see how far they would lose their posture. Afterwards, as a reset action, the subjects were asked to stand up and press their feet several times on the spot. Next, the subjects were seated again, the sample was placed in the subject's jacket pocket, and the same series of shoulder-pressing movements described above was performed again to see if they would lose their balance. Finally, as a confirmation test, the subjects were asked to stand up again, perform the above-mentioned reset motion of stepping on their feet, and then sit down.The subjects then took the sample out of their pockets and performed the same series of motions to check if their posture had deteriorated. Evaluation was performed based on the following criteria. In this test, no variation among subjects was observed, and all subjects exhibited almost the same behavior for the same sample.
[Evaluation criteria]
When the sample was not in the pocket, all subjects lost their balance due to pressure on their shoulders.
×: Even when the sample was inserted, the patient significantly lost his balance when his shoulder was pressed.
△: When the sample was inserted, the loss of posture was clearly smaller than when it was not inserted.
○: When the sample was inserted, almost no loss of posture was observed even when the shoulder was pressed.
［結果］
各サンプルの結果を表１の「簡易バランス試験」の欄に示した。
試験結果の一例として、サンプルＮｏ．１０の粉体組成物を適用したシートを用いた試験を撮影した動画映像からキャプチャーした画像を図４に示す。図４の（ａ－１）、（ａ－２）は、サンプルを入れない状態での試験画像である。（ａ－１）は、実験者が被験者の肩の上に手を置いて下方へ力を加えようとしている場面である。（ａ－２）は、実験者の押す力に負けて、被験者の体勢が崩れた状態である。次に、上記のリセット動作を行ってもらった後に、被験者の上着の右ポケットにサンプルのシートを入れて試験を行った。（ｂ－１）は、これから力を加えようとする場面である。そして、（ｂ－２）は、実験者に力を加えられても被験者がその力に負けずに体勢を崩していない場面である。ふたたびリセット動作を行ってもらった後に、被験者のポケットからサンプルを取出して同様に肩を押して力を加える試験を行ったときの画像が（ｃ－１）、（ｃ－２）である。
[result]
The results of each sample are shown in the "Simple Balance Test" column of Table 1.
As an example of the test results, sample No. FIG. 4 shows an image captured from a video footage of a test using a sheet to which powder composition No. 10 was applied. (a-1) and (a-2) in FIG. 4 are test images with no sample inserted. (a-1) is a scene in which the experimenter places his hand on the subject's shoulder and tries to apply downward force. (a-2) is a state in which the subject's posture collapses due to the pushing force of the experimenter. Next, after performing the above reset operation, the sample sheet was placed in the right pocket of the subject's jacket and a test was conducted. (b-1) is the scene where force is about to be applied. And (b-2) is a scene in which the subject does not lose his posture even when force is applied by the experimenter. Images (c-1) and (c-2) are images of a test in which the sample was taken out of the subject's pocket and pressure was applied by pressing on the subject's shoulder in the same way after the subject performed the reset operation again.
本図から明らかなように、（ａ－２）及び（ｃ－２）のサンプル無しの場合には、被験者の体勢が崩れているのに対して、（ｂ－２）のサンプル有りの場合には、実験者の押す力に負けることなく、（ｂ－１）の状態から体勢がほとんど崩れていないことが分かる。尚、（ａ－２）と（ｃ－２）では、（ｃ－２）の方が被験者の崩れが大きくなっているが、これはキャプチャー瞬間のわずかなズレに基づくもので、何れも被験者が大きく体勢を崩した度合いに有意な差はなかった。ここで、（ａ－２）（ｃ－２）と（ｂ－２）の実験者の体勢の違いに注目すると、（ｂ－２）では実験者は腰を入れて強い力で押していることが伺える。それに比べて、（ａ－２）（ｃ－２）では実験者がそのように強い力を加える前に被験者の体勢が崩れたために、実験者の体勢は力を加える前の（ａ－１）（ｃ－１）からほとんど変わっていない。これらのことからも、サンプル有りの（ｂ－２）では体幹のバランス（身体の重心）を安定させる効果を示していることが分かる。 As is clear from this figure, in cases (a-2) and (c-2) without samples, the subject's posture is collapsed, while in cases (b-2) with samples. It can be seen that the subject did not succumb to the pushing force of the experimenter and his posture hardly collapsed from state (b-1). Furthermore, between (a-2) and (c-2), the subject's collapse is larger in (c-2), but this is due to a slight difference in the capture moment; There was no significant difference in the degree of loss of balance. Here, if we pay attention to the difference in the experimenter's posture in (a-2), (c-2), and (b-2), we can see that in (b-2) the experimenter is pushing with a strong force with his hips. I can hear it. In comparison, in (a-2) and (c-2), the subject's posture collapsed before the experimenter applied such a strong force, so the experimenter's posture changed to (a-1) before applying the force. There has been little change from (c-1). From these results, it can be seen that (b-2) with sample shows the effect of stabilizing the balance of the trunk (center of gravity of the body).
試験１－２ ＜関節の可動域試験＞
表１に示した組成比の各サンプルを配合した印刷用インキを、上記の（１）＜簡易バランス試験＞と同様にして用意した。このインキを用いて、約７０ｃｍ×６０ｃｍの綿布にドットパターンを印刷して本発明の粉体組成物を適用したシートとした。 被験者である成人男女４人に対し、サンプル番号１～１１のうちから無作為に抽出した５～７つのサンプルを割り当てた。ただし、サンプル番号１つあたりの被験者は最低２人となるように調整をおこなった。
Test 1-2 <Joint range of motion test>
Printing inks containing the samples having the composition ratios shown in Table 1 were prepared in the same manner as in (1) <Simple Balance Test> above. Using this ink, a dot pattern was printed on a cotton cloth measuring approximately 70 cm x 60 cm to obtain a sheet to which the powder composition of the present invention was applied. Five to seven samples randomly selected from
［試験方法］
（ｉ）肩関節の可動域テスト
被験者にベンチに座ってもらって両腕を後に伸ばした状態で、後ろから実験者が被験者の両手を持ち、被験者の両腕の間隔がどこまで狭まるかを試験した。最初に、本発明の粉体組成物を適用したシートを用いない状態で被験者の状態を確認した（図５のａ－１）。次に、上記の本発明の粉体組成物を適用したシートを被験者の両肩から上半身に掛けた状態で、同様の試験を行った（図５のａ－２）。
[Test method]
(i) Shoulder joint range of motion test The subject was seated on a bench with both arms extended behind him, and an experimenter held the subject's hands from behind to test how far the distance between the subject's arms could narrow. First, the condition of the subject was confirmed without using the sheet to which the powder composition of the present invention was applied (a-1 in FIG. 5). Next, a similar test was conducted with the sheet to which the above-described powder composition of the present invention was applied placed over both shoulders and upper body of the subject (a-2 in FIG. 5).
（ｉｉ）股関節の可動域テスト（内旋）
まず、被験者にベンチに仰向けに横になってもらう。実験者は一方の手で被験者の踵を持ち、もう一方の手でひざ裏を支える。次に、実験者は被験者の股関節と膝関節をそれぞれ直角に屈曲させる。実験者は、ひざ裏を支えていた手を移動させて被験者のひざ頭押さえる。その状態で被験者のかかとを実験者側に引きつけるようにして、ひざを軸にして被験者の股関節を内旋させる。試験は、まず、本発明の粉体組成物を適用したシートを用いない状態で被験者の状態を確認した（図５のｂ－１）。次に、上記の本発明の粉体組成物を適用したシートを被験者の下半身に掛けた状態で、同様の試験を行った（図５のｂ－２）。
(ii) Hip range of motion test (internal rotation)
First, have the subject lie face up on a bench. The experimenter held the subject's heel with one hand and supported the back of the knee with the other hand. Next, the experimenter flexed the subject's hip and knee joints at right angles. The experimenter moved the hand that was supporting the back of the knee and pressed the subject's kneecap. In this state, pull the subject's heel towards the experimenter and internally rotate the subject's hip joint around the knee. In the test, first, the condition of the test subject was confirmed without using the sheet to which the powder composition of the present invention was applied (b-1 in FIG. 5). Next, a similar test was conducted with the sheet to which the above-described powder composition of the present invention was applied placed over the subject's lower body (b-2 in FIG. 5).
評価は以下の基準により行った。尚、どのサンプルの場合も、（ｉ）肩関節の可動域テストと（ｉｉ）股関節の可動域テスト（内旋）でほぼ同様の結果を示した。
［評価基準］
×：サンプル無しと有りの場合で、関節可動域に差が認められなかった。
△：サンプル有りの場合、サンプル無しのときに比べて若干、可動域が広がった。
○：サンプル有りの場合、サンプル無しのときに比べて明確に可動域が広がった。
Evaluation was performed based on the following criteria. In addition, all samples showed almost the same results in (i) shoulder joint range of motion test and (ii) hip joint range of motion test (internal rotation).
[Evaluation criteria]
×: No difference was observed in joint range of motion between the cases without and with samples.
Δ: With the sample, the range of motion was slightly expanded compared to when there was no sample.
○: With the sample, the range of motion was clearly expanded compared to when there was no sample.
試験１－３ ＜脳波測定試験＞
上記の（２）＜関節の可動域試験＞で使用したものと同じく、表１に示した各サンプルの粉体組成物を適用したシートを、被験者（男性○才代）に身に着けてもらって座位でリラックスした状態で脳波測定を行った。
測定方法：脳波計（ＩＶＢＡ Ｖｅｒ．３）を用いて、 臨床検査技師による脳波および眼球振動測定
測定時間：約１０分
Test 1-3 <Electroencephalogram measurement test>
Similar to the one used in (2) <Joint range of motion test> above, a test subject (male, XX years of age) was asked to wear a sheet to which the powder composition of each sample shown in Table 1 was applied. EEG measurements were performed in a relaxed sitting position.
Measurement method: Electroencephalogram and eye vibration measurement by a clinical laboratory technician using an electroencephalograph (IVBA Ver. 3) Measurement time: Approximately 10 minutes
脳波測定は、まず本発明の粉体組成物を適用したシートを身に着けない状態で測定を始め、約５分経過後に測定を継続したままシートを腹部に当てる等によって身に着けてもらって脳波に変化が生じるかを確認した。得られた脳波データの評価方法は以下の通りである（図６を参照）。測定により図６の（ａ）図のような脳波データを得る。水平長辺方向が時間軸であり、図の右奥から左手前へ向かって時間が進行している。水平短辺方向は測定される脳波の種類を示しており、左奥方向から手前に向かって順に眼球振動δ波、θ波、α波、β波であることを示している。直交縦軸が脳波電圧を示しており、各波形の高さが高いほど脳波電圧が高いことを示している。実測で得られるのは３次元カラー画像であり、脳波電圧が高い部分は赤からピンクに着色され、順に黄-緑-青と低くなる。実測データはこのようにデータの色分けによって脳波の高低が一目瞭然となっているが、本願に添付の図はモノクロ変換したものであるため、主に波形の形状によって以下の説明を行う（適宜、色の違いをグレー濃淡に変換して説明する場合もあり）。 EEG measurement begins with the patient not wearing the sheet to which the powder composition of the present invention has been applied, and after approximately 5 minutes, the patient is asked to wear the sheet by placing the sheet on their abdomen while continuing measurement. We checked to see if there were any changes. The method for evaluating the obtained electroencephalogram data is as follows (see FIG. 6). Through the measurement, brain wave data as shown in FIG. 6(a) is obtained. The horizontal long side direction is the time axis, and time progresses from the back right to the front left of the figure. The direction of the horizontal short side indicates the type of brain waves to be measured, and from the back left toward the front, they are eye vibration δ waves, θ waves, α waves, and β waves. The orthogonal vertical axis indicates the brain wave voltage, and the higher the height of each waveform, the higher the brain wave voltage. The actual measurement results in a three-dimensional color image, where areas with high electroencephalogram voltage are colored from red to pink, and then yellow, green, and blue as the voltage decreases. In the actual measurement data, the height of the brain waves can be clearly seen by color-coding the data in this way, but since the figures attached to this application have been converted to monochrome, the following explanation will mainly be based on the shape of the waveform (colors may be used as appropriate). (Sometimes we explain the differences by converting them into shades of gray.)
図６（ａ）に示すように、３Ｄチャートの一番奥に示される眼球振動の動きによって、被験者の眼球振動の有無を知ることができる。眼球振動が増えると波形が高くなるため、波形が低くかつ山状部分が疎らに見えるほど、眼球振動が少なく被験者がリラックスした状態であることを示す。
図６（ｂ）はδ波を拡大したものであり、本図のδ－１図は被験者がストレスを感じている状態であり、δ－２を経てδ－３に行くほど被験者がリラックスしていることを示している。図においてδ－１及びδ－２図のおける山状や針状に見える部分は脳波電圧が高いことを示すピンクである。δ－３図の突起部はピンクであり、その手前の平坦部は緑－青で示される。
図６（ｃ）図はβ波部分を拡大したものである。こちらも左のβ－１図は被験者がストレスを感じている状態であり、β－２を経てβ－３へ行くほどリラックス状態となる。
β－１及びβ－２の図において白く見える突起状部分は、カラーチャートでは脳波電圧が高いピンクで示された部分であり、β－２とβ－３図の手前側に現れた濃いグレーの平坦部は脳波電圧が一番低い青で示された部分である。その中間にある薄いグレー部分は、カラーチャートでは脳波が低いことを示す緑であった。
As shown in FIG. 6(a), it is possible to know whether or not the subject's eyeballs are vibrating by the movement of the eyeball vibrations shown at the back of the 3D chart. As eyeball vibration increases, the waveform becomes higher; therefore, the lower the waveform and the more sparse the mountain-like portions appear, the less eyeball vibration and the more relaxed the subject is.
Figure 6(b) is an enlarged view of the δ wave, and the δ-1 diagram in this figure shows the state in which the subject is feeling stressed, and the more the subject passes through δ-2 and reaches δ-3, the more relaxed the subject becomes. It shows that there is. In the figure, the mountain-like or needle-like parts in the δ-1 and δ-2 diagrams are pink, indicating high brain wave voltage. The protruding part in the δ-3 diagram is shown in pink, and the flat part in front of it is shown in green-blue.
FIG. 6(c) is an enlarged view of the β wave portion. The β-1 diagram on the left is also a state in which the subject is feeling stressed, and as the subject passes through β-2 and moves to β-3, the subject becomes more relaxed.
The protruding parts that appear white in the diagrams β-1 and β-2 are the parts shown in pink with high electroencephalogram voltage on the color chart, and the dark gray parts that appear on the front side of the diagrams β-2 and β-3 are the parts shown in pink on the color chart. The flat part is the part shown in blue where the electroencephalogram voltage is lowest. The light gray area in between was green on the color chart, indicating low brain waves.
［評価基準］
以上を踏まえて、測定により得られた脳波データから以下の基準によって本発明の粉体組成物を適用した各サンプルのシートについて、被験者に対するリラクゼーション効果の有無を確認した。評価は主に、眼球振動とβにおける波形に現れた山の数及び山の高さ変化により以下の通りとした。
○：被験者がシートを身に着ける前後で顕著にδ波とβ波にリラックス傾向が現れた
△：被験者がシートを身に着ける前後で、δ波とβ波にリラックス傾向が認められるがその度合いが小さい
×：被験者がシートを身に着ける前後で、δ波とβ波にリラックス傾向が現れたとまでは言えない
ここで、○評価と△評価の違いについては、例えば図６（ｂ）において、δ－１からδ－３へ変化した場合や、（ｃ）においてβ－１からβ－３へ変化した場合のような顕著な減少が認められたときは○評価とした。変化度合がδ－１からδ－２へ程度だった場合や、β－１からβ－２へ程度のように、大きく減少したとまでは言えないものの明らかに減少したと認識できた場合には△評価とした。そして、グラフ上の変化が僅かであるため明らかに減少したとまでは認識できない場合、又は全く減少が認められない場合は、×評価とした。結果は表１に示した。
[Evaluation criteria]
Based on the above, it was confirmed whether or not each sample sheet to which the powder composition of the present invention was applied had a relaxation effect on the subject based on the electroencephalogram data obtained by measurement according to the following criteria. The evaluation was mainly based on the number of peaks appearing in the waveform of eyeball vibration and β, and the change in the height of the peaks as follows.
○: There was a noticeable tendency to relax in the δ and β waves before and after the subject put on the sheet. △: There was a tendency to relax in the δ and β waves before and after the subject put on the sheet, but to what extent. is small ×: It cannot be said that there was a tendency to relax in δ waves and β waves before and after the subject put on the sheet. Here, regarding the difference between ○ evaluation and △ evaluation, for example, in Fig. 6 (b), When a remarkable decrease was observed, such as when changing from δ-1 to δ-3 or from β-1 to β-3 in (c), it was evaluated as ○. When the degree of change is from δ-1 to δ-2, or from β-1 to β-2, it cannot be said that there has been a large decrease, but it can be recognized that there has been a clear decrease. It was evaluated as △. If the change on the graph is so slight that it cannot be clearly recognized as a decrease, or if no decrease is observed at all, it is rated as ×. The results are shown in Table 1.
比較例であるサンプルＮｏ.１～６では、脳波データから被験者がリラックス状態に遷移したことは読み取れなかった。唯一、サンプルＮｏ.４のみは、シート着衣によってリラックス方向へ波形が変化したと認められる部分もあったがその度合いは小さく、また、ほぼ変化なしと言える部分もありシートの効果としてはやや疑問であった。本発明の実施例であるサンプルＮｏ．７～１０は、シート着衣により被験者がリラックス状態になったことを示す顕著な波形変化が認められた。サンプルＮｏ．１１についてもリラックス状態への明らかな波形変化が認められたが、その変化度合が小さいため△評価とした。以上より、ラジウム粉末と炭化粉のいずれか一方のみ（サンプルＮｏ．１及び２）ではリラクゼーション効果がないことが確認された。同時に、ラジウム粉末と炭化粉の両方を含有するのみ（サンプルＮｏ．３～６）ではリラクゼーション効果は得られず、特定の比率で両方を含有する場合(サンプルＮｏ．７～１１)にのみリラクゼーション効果を有することが確認された。 In samples Nos. 1 to 6, which are comparative examples, it could not be seen from the electroencephalogram data that the subjects had transitioned to a relaxed state. Only in sample No. 4, there were parts where it was recognized that the waveform changed in the direction of relaxation due to wearing the seat, but the degree of change was small, and there were also parts where it could be said that there was almost no change, so the effect of the seat is somewhat questionable. there were. Sample No. which is an example of the present invention. In samples 7 to 10, a significant change in waveform was observed indicating that the subject became relaxed by wearing the sheet. Sample No. Although a clear change in the waveform toward a relaxed state was also observed for No. 11, the degree of the change was small, so it was rated △. From the above, it was confirmed that using only either the radium powder or the carbonized powder (sample Nos. 1 and 2) had no relaxation effect. At the same time, the relaxation effect cannot be obtained only by containing both radium powder and carbonized powder (Samples No. 3 to 6), but only by containing both in a specific ratio (Samples No. 7 to 11). It was confirmed that the
試験１－４ ＜被験者の効果実感アンケート＞
本発明の粉体組成物を適用したシートを２日から１０日程の間、日常生活で体に装着してもらい、なんらかの効果が感じられたかについてアンケート調査を行った。各被験者は、本発明の粉体組成物を適用したシートを、自身が日常生活で使用し易い形状となるようにカットしたものを身体に装着した。表１に示したサンプルＮｏ．３～１１について、各サンプル毎に１３人から１５人を被験者とした。被験者は、１０代～７０代の男女である。以下に示すような、何らかの効果を実感したと思われる回答について肯定的意見とし、装着前と比べて大きな変化が現れたとまで言えない場合は肯定的意見としてはカウントしていない。尚、装着することで症状が悪化したというような完全な否定的意見は全くなかった。各サンプル毎に、（肯定的意見を得た人数／当該サンプルの被験者数）により肯定的意見の％を求め、得られた値の一の位を四捨五入して１０％毎の値として表１に結果を示した。
Test 1-4 <Subjects' effectiveness questionnaire>
Participants were asked to wear a sheet to which the powder composition of the present invention was applied on their bodies in their daily lives for 2 to 10 days, and a questionnaire survey was conducted to determine whether any effects were felt. Each test subject wore a sheet to which the powder composition of the present invention had been applied, which was cut into a shape that was easy for the test subject to use in daily life. Sample No. shown in Table 1. For samples 3 to 11, 13 to 15 people were subjects for each sample. The subjects were men and women from their teens to their 70s. As shown below, responses that indicate that some kind of effect was felt are considered positive opinions, and cases where it cannot be said that there has been a significant change compared to before wearing are not counted as positive opinions. Furthermore, there were no completely negative opinions such as that the symptoms were worsened by wearing the device. For each sample, calculate the percentage of positive opinions by (number of people who received positive opinions/number of subjects in the sample), round the obtained value to the nearest tenth, and show the values in 10% increments in Table 1. The results were shown.
［肯定的意見の例］
・円状にカットしたシートをインソールとして靴の中に入れたり、ズボンのポケットに入れて使用したところ、通勤時に疲労が軽減して電車内で立ちっ放しでも苦にならなくなった。
・アイマスクとして使用することで、目の疲労回復が実感できたと共に、ものが見易くなった気がする。
・メガネの弦にシートを巻いて使用したところ、眼精疲労の回復を感じる事ができ、以前よりはっきりと物が見えるようになったと感じる。
・自動車の運転時に、座席にシートを敷いて使用したところ、目が疲れることがなくなり、体の疲れもたまらなくなった。
・シートを折り畳んでベルト状として首に巻いて使用したところ、以前より体のだるさを感じなくなった。
・就寝時に頭や背中の下にシートを敷いて寝たところ熟睡できた。
[Example of positive opinion]
- When I used a circularly cut sheet as an insole in my shoes or in my pants pocket, I felt less fatigue while commuting, and I didn't have to worry about standing on the train.
・By using it as an eye mask, I was able to feel relief from eye fatigue and I felt like I could see things more easily.
・When I wrapped the sheet around the strings of my glasses, I was able to feel relief from eye strain, and I felt like I was able to see things more clearly than before.
・When I used a sheet on my seat when driving a car, my eyes no longer became tired and my body felt less tired.
・When I folded the seat and used it as a belt around my neck, I felt less sluggish than before.
・When I went to bed, I put a sheet under my head and back and slept soundly.
［総合評価］
以上の試験１－１～試験１－４の結果から、各サンプルについてリラクゼーション効果の有無を総合的に評価して結果を表１に示した。サンプルＮｏ．４～６は簡易バランス試験の結果は良好であったが、脳波測定試験においてはリラクゼーション効果が認められなかったことから総合評価は×とした。本発明の実施例であるサンプルＮｏ．７～１１は、簡易バランス試験のみならず、脳波試験においても良好なリラクゼーション効果が認められた。また、これらの実施例サンプルＮｏ．７～１１では、関節可動域試験の結果も良好であった。尚、試験１－４のアンケート調査における肯定的意見（％）は、主観的なものであるため、総合評価を出すにあたっては判断材料としていない。
[comprehensive evaluation]
Based on the results of Tests 1-1 to 1-4 above, each sample was comprehensively evaluated for the presence or absence of a relaxation effect, and the results are shown in Table 1. Sample No. For items 4 to 6, the results of the simple balance test were good, but no relaxation effect was observed in the electroencephalogram measurement test, so the overall evaluation was given as ×. Sample No. which is an example of the present invention. Tests 7 to 11 had good relaxation effects not only in the simple balance test but also in the electroencephalogram test. In addition, these example sample No. For children 7 to 11, the joint range of motion test results were also good. Furthermore, since the positive opinions (%) in the questionnaire survey for Tests 1-4 are subjective, they are not used as a basis for determining the overall evaluation.
炭化粉の作成方法によって効果が異なるかを以下の試験により確認した。入手した稲のもみ殻を、焼却炉で表２の焼成温度及び焼成時間で焼成することで、もみ殻くん炭を作成し、それを粉砕して微粒粉末としたものを炭化粉とした。ラジウム粉末は、ラジウム天然鉱石を粉砕して微粒粉末とした市販品を用いた。実施例１で示した表１のサンプルＮｏ．９と同様に、ラジウム１重量部に対して、炭化粉を１０重量部の割合で混合して本発明の粉体組成物とした。当該粉体組成物を用いて実施例１における（１）＜簡易バランス試験＞と同様の方法にて印刷を介してシートを作成した。 The following test was conducted to confirm whether the effects differ depending on the method of preparing carbonized powder. The obtained rice husks were fired in an incinerator at the firing temperature and firing time shown in Table 2 to create rice husk charcoal, which was ground into fine powder to obtain carbonized powder. As the radium powder, a commercially available product obtained by crushing natural radium ore into fine powder was used. Sample No. 1 in Table 1 shown in Example 1. Similarly to Example 9, carbonized powder was mixed at a ratio of 10 parts by weight to 1 part by weight of radium to obtain a powder composition of the present invention. A sheet was created by printing using the powder composition in the same manner as (1) <simple balance test> in Example 1.
試験２－１ ＜脳波測定試験＞
実施例１の試験１－３＜脳波測定試験＞と同様の方法で脳波測定を行い、同基準にて評価を行った。結果を表２に示した。
試験２－２ ＜被験者の効果実感アンケート＞
実施例１の試験１－４＜被験者の効果実感アンケート＞と同様の方法で、被験者の使用実感を調査した。得られた回答の内、どの程度の肯定的意見があったかを表２に示した。
Test 2-1 <Electroencephalogram measurement test>
Electroencephalogram measurements were performed in the same manner as in Test 1-3 <Electroencephalogram measurement test> of Example 1, and evaluations were made based on the same criteria. The results are shown in Table 2.
Test 2-2 <Subjects’ effectiveness questionnaire>
Test subjects' experience of use was investigated in the same manner as in Test 1-4 <Subjects' experience of effectiveness questionnaire> of Example 1. Table 2 shows how many positive opinions there were among the responses obtained.
［総合評価］
前記の試験２－１＜脳波測定試験＞及び試験２－２＜被験者の効果実感アンケート＞の結果から総合評価を行って表２に示した。特に脳波測定試験の結果から、７００～１５００℃で１～５時間焼成した炭化粉を用いたサンプル（本願発明の実施例であるサンプルＮｏ．２５～２９）で優れたリラックス効果が認められた。しかし、比較例を見ると、サンプルＮｏ．２３～２５のように焼成温度が７００～１５００℃の範囲内であっても焼成時間が長い場合には、脳波データから読み取れるリラックス効果が弱いか、全く効果を示していないことが分かった。
[comprehensive evaluation]
A comprehensive evaluation was made from the results of Test 2-1 <Electroencephalogram measurement test> and Test 2-2 <Subject's effect questionnaire> and is shown in Table 2. In particular, the results of the electroencephalogram measurement test showed that samples using carbonized powder baked at 700 to 1500°C for 1 to 5 hours (Samples No. 25 to 29, which are examples of the present invention) had an excellent relaxing effect. However, when looking at comparative examples, sample No. It was found that when the firing time was long even when the firing temperature was within the range of 700 to 1500°C, as in cases 23 to 25, the relaxing effect as seen from the brain wave data was weak or did not show any effect at all.
本試験における炭化粉を作成する際の焼成温度の設定は、焼却炉の温度設定ダイヤルを用いて行ったものであるため、それが焼却時間内における最高到達温度となる。実施例であるサンプルＮｏ．２６～２９は、設定した時間内に炭化させるために、焼成スタートから強い火力を用いることとなった。これにより、サンプルＮｏ．２６～２９は短時間で設定した到達最高温度に到達して焼成されることとなった。これに対してサンプルＮｏ．２１～２５は設定した焼成時間に余裕がありスタートから強い火力を用いる必要がなかったため、焼成スタート時から最高到達温度に達するまでにより長い時間がかかった。結果的に、比較例であるサンプルＮｏ．２１～２４は低温長時間焼成に近い焼成となり、実施例であるサンプルＮｏ．２５～２９は高温短時間焼成となった。サンプルＮｏ．２２と２５、２３と２６、２４と２７のように同じ焼成温度であっても効果に違いが出たのはこのためと考えられる。尚、サンプルＮｏ．２３及びＮｏ．２６の炭化粉についてケイ素含有量を分析したところ、Ｎｏ．２３では４０％であったのに対してＮｏ．２６では９５％であった。 The firing temperature when creating the carbonized powder in this test was set using the temperature setting dial of the incinerator, so this was the highest temperature reached within the firing time. Sample No. which is an example. For Nos. 26 to 29, strong heat was used from the start of firing in order to carbonize within the set time. As a result, sample No. Items 26 to 29 reached the set maximum temperature in a short time and were fired. On the other hand, sample no. For Nos. 21 to 25, there was ample time in the set firing time and there was no need to use strong heat from the start, so it took a longer time from the start of firing to reach the maximum temperature. As a result, sample No., which is a comparative example. Samples No. 21 to 24 were fired close to low-temperature, long-time firing, and sample No. 21 was an example. Items 25 to 29 were fired at high temperature and for a short time. Sample No. This is thought to be the reason why there were differences in effects even at the same firing temperature, such as in Nos. 22 and 25, 23 and 26, and 24 and 27. In addition, sample No. 23 and no. When the silicon content of No. 26 carbonized powder was analyzed, No. In No. 23, it was 40%; 26, it was 95%.
試験２－３ ＜無機ケイ素を用いた試験＞
上記の試験２－１及び２－２の結果について、ケイ素含有量の問題であるかを以下の試験により確認した。市販のカーボン粉末と金属シリコーン粉末を混合し、ケイ素含有量が表３に示した割合になるように各サンプルを調整した。使用した金属シリコーン粉末中のケイ素含有量は約９９％である。表３はカーボン粉末と金属シリコーン粉末の混合割合を示したもので、表中の１００％とは、カーボン粉末を全く混合しないことを意味する。
Test 2-3 <Test using inorganic silicon>
Regarding the results of Tests 2-1 and 2-2 above, it was confirmed by the following test whether the problem was due to the silicon content. Commercially available carbon powder and metal silicone powder were mixed and each sample was adjusted so that the silicon content would be in the ratio shown in Table 3. The silicon content in the metal silicone powder used is approximately 99%. Table 3 shows the mixing ratio of carbon powder and metal silicone powder, and 100% in the table means that no carbon powder is mixed at all.
［評価基準］
実施例１と同様に脳波測定を行い以下の基準で評価を行った。
△：被験者がシートを身に着ける前後で、眼球振動とβ波にリラックス傾向が認められるがその度合いが小さい
×：被験者がシートを身に着ける前後で、眼球振動とβ波にリラックス傾向が現れたとまでは言えない
[Evaluation criteria]
Electroencephalogram measurements were performed in the same manner as in Example 1, and evaluations were made based on the following criteria.
△: There is a tendency to relax in the eyeball vibrations and β waves before and after the subject puts on the sheet, but the degree of relaxation is small ×: A tendency to relax in the eyeball vibrations and β waves before and after the subject puts on the sheet. I can't say that
表３に示した評価結果から、ケイ素含有率３５～９８％の炭粉を用いて本発明の粉体組成物を作成した場合に、被験者に対するリラクゼーション効果が見られた。しかしながら、植物由来のくん炭を使用した場合に比べると、その効果は明らかに弱かった。この結果から、ケイ素含有量によりリラクゼーション効果が異なる事が分かったが、無機ケイ素を用いた場合には、植物素材を焼成することで作成したくん炭を用いた炭化粉よりも効果が弱い結果となった。 From the evaluation results shown in Table 3, when the powder composition of the present invention was prepared using charcoal powder with a silicon content of 35 to 98%, a relaxation effect on the test subjects was observed. However, the effect was clearly weaker than when using plant-derived charcoal. From this result, it was found that the relaxation effect differs depending on the silicon content, but when inorganic silicon was used, the effect was weaker than that of carbonized powder using Kunchar made by burning plant material. became.
各成分を表４の比率（重量部）で混合して作成した各サンプル番号の粉体組成物を用いてゲルマニウム及び銅を添加した場合の効果について確認を行った。各粉体組成物を用いて、実施例１と同様の方法で印刷を介してシートを作成した。尚、各粉体組成物におけるラジウムは、ラジウム天然鉱石を粉砕して微粒粉末とした市販品を用いた。炭化粉は、入手した稲のもみ殻を燃焼炉により８００℃で４時間焼成することで、もみ殻くん炭を作成し、それを粉砕して微粒粉末としたものを用いた。それぞれの微粒粉末の粒径は概ね７μｍとした。試験は、実施例１と同じ方法で＜簡易バランス試験＞と＜脳波測定試験＞を行った。それぞれの試験の評価方法についても実施例１と同様である。各試験の結果及び総合評価について表４に示した。 The effect of adding germanium and copper was confirmed using powder compositions of each sample number prepared by mixing each component at the ratio (parts by weight) shown in Table 4. Using each powder composition, sheets were created by printing in the same manner as in Example 1. As the radium in each powder composition, a commercially available product obtained by crushing natural radium ore into fine powder was used. The carbonized powder was prepared by burning the obtained rice husks at 800° C. for 4 hours in a combustion furnace to create rice husk charcoal, which was then ground into fine powder. The particle size of each fine powder was approximately 7 μm. The tests were conducted in the same manner as in Example 1, including a <simple balance test> and an <electroencephalogram measurement test>. The evaluation method for each test was also the same as in Example 1. Table 4 shows the results of each test and the overall evaluation.
この結果より、ラジウム及び炭化粉の一方のみしか含まない粉体組成物（サンプルＮｏ．４１～４３）では、ゲルマニウムや銅を添加してもリラクゼーション効果を示すことはなかった。また、ラジウムと炭化粉の組成比が本発明の組成比から外れている粉体組成物（サンプルＮｏ．４４）についてもゲルマニウムや銅を添加しても効果を示すことはなかった。これに対して、本発明の実施例であるサンプル４５～４８では、ゲルマニウムや銅を更に添加することで、ラジウムを減量できることが分かる。サンプルＮｏ．１０とＮｏ．４５の比較では、ゲルマニウムや銅を含有しないサンプルＮｏ．１０が十分なリラクゼーション効果を示すため、ゲルマニウムや銅を添加する効果はほとんど見られない。しかし、サンプルＮｏ．１１とサンプルＮｏ．４６～４８の比較で顕著なように、炭化粉に対してゲルマニウムの含有量が少ないためにリラクゼーション効果がやや弱かったサンプルＮｏ．１１であっても、ゲルマニウムや銅の一方若しくは両方を添加することによって、ラジウム含有量の高いサンプルＮｏ．１０と同様のリラクゼーション効果が得られることが脳波試験の結果から分かる。 From this result, powder compositions containing only one of radium and carbonized powder (sample Nos. 41 to 43) did not exhibit a relaxation effect even when germanium or copper was added. Further, even with the powder composition (sample No. 44) in which the composition ratio of radium and carbonized powder deviated from the composition ratio of the present invention, no effect was exhibited even when germanium or copper was added. On the other hand, in samples 45 to 48, which are examples of the present invention, it can be seen that the amount of radium can be reduced by further adding germanium and copper. Sample No. 10 and no. In the comparison of sample No. 45, sample No. 45 contains no germanium or copper. Since No. 10 shows a sufficient relaxation effect, almost no effect of adding germanium or copper is seen. However, sample no. 11 and sample no. As is noticeable in the comparison of samples No. 46 to 48, sample No. 4 had a slightly weaker relaxation effect due to the lower germanium content compared to the carbonized powder. Even if sample No. 11 has a high radium content, by adding one or both of germanium and copper, sample No. It can be seen from the results of the electroencephalogram test that the same relaxation effect as No. 10 can be obtained.
以上の実施例の試験において特に効果を示した粉体組成物（表１サンプルＮｏ．９）について、印刷を介して本発明の粉体組成物を適用した様々な物品を作成し、被験者数を増やして脳波測定を行った。 Regarding the powder composition (Sample No. 9 in Table 1) that was particularly effective in the tests of the above examples, various articles were created to which the powder composition of the present invention was applied through printing, and the number of test subjects was We increased the number of patients and performed electroencephalogram measurements.
試験４－１（シートによる試験）
被験者の両肩に本願発明のシート（大きさ約３０ｃｍ×２０ｃｍ）を掛け、椅子に着席しリラックスした状態で脳波測定を行った。
・被験者Ａ：４０代女性
得られた測定結果を図７に示した。
シート装着前、β波は標準より低めであったが眼球振動を示すδ波がやや高めに出ており、若干の緊張状態にあったと考えられる。
シートを装着した直後より、β波と眼球振動共に低下が認められた。特に眼球振動はピークの出現が疎らになり眼球振動が低下したことを示す。β波も同時に低下していることから、緊張状態から心身が弛緩したリラックス状態に遷移したと考えられる。
・被験者Ｂ：６０代女性
得られた測定結果を図８に示した。
シート装着前からβ波眼球振動共に標準よりやや低めであった。シート装着後は、β波は若干の低下に留まったが、眼球振動は顕著に低下し、眼球振動が抑制されたことが分かる。また、装着後はα波の活発化が見られたことから、心身リラックス状態となり副交感神経が優位になったと考えられる。
Test 4-1 (sheet test)
The sheet of the present invention (approximately 30 cm x 20 cm in size) was placed over both shoulders of the test subject, and brain waves were measured while the test subject was seated in a relaxed state.
- Subject A: Female in her 40s The measurement results obtained are shown in FIG.
Before wearing the seat, the beta waves were lower than normal, but the delta waves, which indicate eyeball vibration, were slightly higher, suggesting that the patient was in a slightly nervous state.
Immediately after wearing the sheet, a decrease in both beta waves and eyeball vibrations was observed. In particular, the appearance of peaks for eyeball vibrations became sparse, indicating that eyeball vibrations decreased. Since the beta waves also decreased at the same time, it is thought that the patient transitioned from a tense state to a relaxed state in which the mind and body relaxed.
- Subject B: Female in her 60s The measurement results obtained are shown in FIG.
Even before the seat was installed, the β-wave eyeball vibrations were both slightly lower than standard. After wearing the sheet, β waves were only slightly reduced, but eyeball vibrations were significantly reduced, indicating that eyeball vibrations were suppressed. Furthermore, after wearing the device, α-wave activation was observed, which suggests that the mind and body were in a relaxed state, and the parasympathetic nervous system became dominant.
・被験者Ｃ：５０代男性
得られた測定結果を図９に示した。
シート装着前は、β波は低め傾向にあったものの、眼球振動は高めに出ており緊張状態であったことが伺える。シート装着後は、β波部分は低下しフラットに近い状態となった。また、眼球振動も低下が認められ、眼球振動が低下したことを示している。脳波全体から、深いリラックス状態となって副交感神経優位になったと考えられる。
・被験者Ｄ：非公開
得られた測定結果を図１０に示した。
シート装着前は、眼球振動が高めであり眼球振動が活発であったことを示している。シート装着後は、眼球振動を示すδ波のピークが疎らとなって低下傾向を示し、眼球振動が抑制されたことが分かる。β波は装着前後で顕著な違いが認められなかったが、装着によりα波の活性化が認められ、副交感神経が優位となった心身リラックス状態になったと考えられる。
・被験者Ｅ：非公開
得られた測定結果を図１１に示した。
シート装着前は、δ波から眼球振動が若干高めであったことが分かる。シート楚着後は、δ波が大きく減少し眼球振動が安定したことが分かる。また、β波もシート装着によって減少が認められ、リラックス状態に遷移したと考えられる。
- Subject C: Male in his 50s The measurement results obtained are shown in FIG.
Before wearing the seat, the beta waves tended to be low, but the eyeball vibrations were high, indicating that the patient was in a nervous state. After the seat was installed, the β wave portion decreased and became almost flat. Furthermore, a decrease in eyeball vibration was observed, indicating that eyeball vibration had decreased. Based on the overall brain waves, it is thought that he was in a deep state of relaxation and his parasympathetic nervous system became dominant.
- Subject D: Not disclosed The obtained measurement results are shown in FIG. 10.
Before wearing the seat, the eyeball vibration was high, indicating that the eyeball vibration was active. After wearing the sheet, the peaks of the δ waves, which indicate eyeball vibration, became sparse and showed a downward trend, indicating that eyeball vibration was suppressed. Although no significant difference was observed in beta waves before and after wearing the device, activation of alpha waves was observed after wearing the device, suggesting that the parasympathetic nervous system became dominant, resulting in a state of mental and physical relaxation.
- Subject E: Not disclosed The obtained measurement results are shown in FIG. 11.
Before wearing the seat, it can be seen from the δ waves that the eyeball vibration was slightly higher. It can be seen that after the sheet was folded, the δ waves decreased significantly and the eyeball vibration became stable. Furthermore, beta waves were also observed to decrease as a result of wearing the seat, suggesting a transition to a relaxed state.
試験４－２（シート用いた着席－立位での試験）
シート未装着で着席した状態 → 着席して足裏にシートを装着した状態 → 足裏にシートを装着したままで起立し立位状態と、装着－未装着及び姿勢の変化を行いながら脳波測定を行った。
・被験者Ａ：４０代女性
得られた測定結果を図１２に示した。
着席状態のまま、被験者の足裏にシートを敷くと、β波と眼球振動が共に低下した。
次に、立位の状態で足裏にシートを敷いた状態では、β波のピークが更に疎らになって低が認められた。δ波は、ピークの出現数が増加し、眼球振動が若干活発化したことが伺える。ただし、同時にリラックス状態になると増加するα波とθ波の活発化が認められることから、深いリラックス状態で副交感神経が優位になった状態は維持されていると考えられる。このことから、δ波の増加は、血流がよくなったことによる眼球運動の活発化に伴うものであると考察される。
Test 4-2 (sitting-standing test using a seat)
EEG measurements were taken while seated without the seat attached → seated with the seat attached to the soles of the feet → standing with the seat attached to the soles of the feet, and while wearing and not wearing the seat and changing posture. went.
- Subject A: Female in her 40s The measurement results obtained are shown in FIG. 12.
When a sheet was placed on the soles of the subjects' feet while they were seated, both beta waves and eyeball vibrations decreased.
Next, in a standing position with a sheet placed on the soles of the feet, the peaks of the beta wave became more sparse and lower. The number of peaks in δ waves increased, indicating that eyeball vibrations became slightly more active. However, at the same time, activation of alpha waves and theta waves, which increase when a person enters a relaxed state, is observed, so it is thought that the parasympathetic nervous system remains dominant in a deeply relaxed state. From this, it is considered that the increase in δ waves is due to activation of eye movements due to improved blood flow.
・被験者Ｂ：６０代女性
得られた測定結果を図１３に示した。
着席状態でシート装着前のδ波は、ピークの高さは低いものの連続的に出現していた。着席状態のままシートを足裏に敷いた後は、ピークが高くはなったが出現頻度の低下が見られ、眼球振動の低下が認められた。次に、立位で足裏に敷いた状態では、更にδ波の出現頻度が低下しピークの高さも低くなった。また、β波は緩やかに減少しており、９分頃以降は脳波全体がフラットになり、心地よく心身がリラックスして副交感神経優位の状態にあると考えられる
・被験者Ｃ：５０代男性
得られた測定結果を図１４に示した。
着席状態のまま足裏にシートを敷くと、β波に若干の低下が見られたものの、δ波は若干の活性化が見られた。
次に、立位で足裏にシートを敷いた状態では、β波の更なる低下が見られた。また、δ波についても徐々に低下傾向であることが認められた。δ波は高いものの、β波部分はフラットに近くなっており、メンタル的にはリラックスした状態だったと考察される。この状態で身体の活性化（眼球振動）が見られることから、δ波の活性は血流が良くなったことに伴うものと考えることができる。
- Subject B: Female in her 60s The measurement results obtained are shown in FIG. 13.
In the seated state and before the seat was installed, the δ waves appeared continuously, although the peak height was low. After the seat was placed on the soles of the feet while seated, the peaks were higher, but the frequency of occurrence decreased, and a decrease in eye vibration was observed. Next, when the pad was placed on the soles of the feet in a standing position, the frequency of δ waves further decreased and the peak height also decreased. In addition, beta waves gradually decreased, and after about 9 minutes, the brain waves as a whole became flat, indicating that the body and mind were comfortably relaxed and in a state where the parasympathetic nervous system was dominant.Subject C: Male in his 50s Obtained. The measurement results are shown in FIG.
When a sheet was placed under the soles of the feet while seated, there was a slight decrease in beta waves, but a slight activation of delta waves.
Next, in a standing position with a sheet placed on the soles of the feet, a further decrease in beta waves was observed. It was also observed that the δ waves were also gradually decreasing. Although his delta waves were high, his beta waves were nearly flat, suggesting that he was in a mentally relaxed state. Since physical activation (eyeball vibration) is observed in this state, it can be considered that the activity of delta waves is associated with improved blood flow.
試験４－３（腹まきによる試験）
一辺が概ね３０ｃｍ弱の略正方形の本願発明のシートを広げた状態で腹部の上に乗せ、椅子に着席したリラックス姿勢を取ってもらって脳波測定を行った。（図１５（ａ）を参照）測定スタート時には、腹まき未装着で測定を行い、概ね５分前後経過した後に腹まきを装着してもらい、そのまま脳波測定を継続した。
・被験者Ｆ：４０代男性
得られた測定結果を図１６に示した。
装着により、δ波、β波共に著しく低下した。眼球振動が低下しリラックス状態へ遷移したことが認められた。
Test 4-3 (belly wrap test)
The sheet of the present invention, which was approximately square with a side of about 30 cm, was spread out and placed on the abdomen, and the subjects were asked to take a relaxed posture while sitting on a chair, and brain waves were measured. (See FIG. 15(a)) At the start of the measurement, the measurement was performed without wearing the abdominal wrap, and after about 5 minutes, the subjects were asked to put on the belly wrap, and the brain wave measurement was continued.
- Subject F: Male in his 40s The measurement results obtained are shown in FIG. 16.
After wearing it, both delta waves and beta waves decreased significantly. It was observed that the eyeball vibration decreased and the patient transitioned to a relaxed state.
・被験者Ｇ：５０代男性
得られた測定結果を図１７に示した。
装着後は、デルタ波が大きく低下し眼球振動が抑制されたことが分かる。β波は未装着時の測定値でも低め傾向ではあったが時折やや高いピークが出現していた。装着後は、それらのピークが消失し、装着後はよりリラックス傾向へ遷移したことが分かる。
・被験者Ｈ：４０代男性
得られた測定結果を図１８に示した。
装着前は、δ波β波共に高め傾向であった。装着後は、δ波の高さと出現頻度が低下し眼球振動が抑制されたことが分かる。β波も装着によって大きく低下し、リラックス状態へと遷移したことが分かる。
- Subject G: Male in his 50s The measurement results obtained are shown in FIG. 17.
After wearing the device, delta waves decreased significantly, indicating that eyeball vibration was suppressed. Beta waves tended to be low even when the device was not worn, but slightly higher peaks occasionally appeared. It can be seen that these peaks disappeared after wearing the device, and the user became more relaxed after wearing the device.
- Subject H: Male in his 40s The measurement results obtained are shown in FIG. 18.
Before installation, both delta and beta waves tended to be high. After wearing the device, the height and frequency of δ waves decreased, indicating that eyeball vibration was suppressed. It can be seen that beta waves also decreased significantly after wearing the device, indicating a transition to a relaxed state.
試験４－４（ＩＤカード状のシートによる試験）
概ね１０ｃｍ×７ｃｍ弱のＩＤカードケースより一回り程小さい大きさとした本願発明のシートを、ＩＤカードケースに入れて被験者の首から掛けてもらい着席状態で脳波測定を行った（図１５（ｂ）を参照）。
・被験者Ｈ：４０代男性
得られた測定結果を図１９に示した。
装着により、δ波とβ波共に著しく低下し、リラックス状態に遷移している事を示している
・被験者Ｉ：３０代女性
得られた測定結果を図２０に示した。
装着により、β波のピークが消失し全体的にフラットに近づいていることが認められる。また、δ波はピークの密度が明らかに低下し全体に疎らとなった。これらのことより、カードの装着により被験者がリラックス状態に遷移したことが読み取れる。
Test 4-4 (test using ID card-like sheet)
The sheet of the present invention, which is approximately 10 cm x 7 cm smaller than an ID card case, was placed in the ID card case and hung around the neck of the subject, and brain waves were measured while the subject was seated (Figure 15(b)) ).
- Subject H: Male in his 40s The measurement results obtained are shown in FIG. 19.
By wearing the device, both δ and β waves decreased significantly, indicating a transition to a relaxed state.Subject I: Female in her 30s The measurement results obtained are shown in Figure 20.
After wearing the device, the peak of the beta waves disappeared and the overall shape became nearly flat. In addition, the peak density of the δ waves clearly decreased and became sparse overall. From these facts, it can be seen that the subject transitioned to a relaxed state by wearing the card.
試験４－５（枕カバーによる試験）
リクライニングシートの頭部接触部に大きめの枕を設置して、本願発明のシートを枕の上に敷き、その上に頭部を乗せた状態でシートをリクライニングしてリラックス姿勢を取ってもらって脳波測定を行った。
・被験者Ｉ：３０代女性
得られた測定結果を図２１に示した。
未装着時は、眼球振動を示すδ波が大きく見られた。装着により、δ波が大きく低下し眼球振動が減少したことが認められる。未装着時からやや低め傾向であったβ波についても、未装着時に見られていた低いピークが減少して全体的にピークの少ない平面的なグラフとなり、よりリラックス傾向へ遷移したことが認められた。
・被験者Ｆ：４０代男性
得られた測定結果を図２２に示した。
未装着時には、δ波はやや疎らながら明確なピークが認められ、β波についても小さいピークがやや密に認められていた。装着後は、δ波、β波共に低下したことがはっきりを分かる。
Test 4-5 (Test using pillow cover)
A large pillow is placed in the head contact area of the reclining seat, the sheet of the present invention is placed on top of the pillow, and with the head resting on the pillow, the seat is reclined to take a relaxed posture, and the brain waves are measured. I did it.
- Subject I: Female in her 30s The measurement results obtained are shown in FIG. 21.
When not wearing the device, large delta waves, which indicate eyeball vibration, were visible. It was observed that by wearing the device, δ waves were significantly reduced and eyeball vibration was reduced. Regarding beta waves, which had been trending slightly lower since the time the device was not worn, the low peak that was seen when the device was not worn decreased, resulting in a flat graph with fewer peaks overall, and it was observed that the graph transitioned to a more relaxed tendency. Ta.
- Subject F: Male in his 40s The measurement results obtained are shown in FIG. 22.
When the device was not worn, δ waves had clear peaks that were slightly sparse, and β waves also had small peaks that were slightly densely observed. After wearing it, it is clearly seen that both delta waves and beta waves have decreased.
試験４－６（メガネの弦に巻きつけての試験）
概ね２０ｃｍ×３ｃｍの長方形の本願発明のシートを弦部分に巻きつけたメガネを装着し、椅子に着席したリラックス姿勢を取ってもらって脳波測定を行った。
・被験者Ｉ：３０代女性
得られた測定結果を図２３に示した。
装着前後で、δ波β波共に明らかに低下していることが分かる。
Test 4-6 (Test wrapped around the string of glasses)
Brain waves were measured while the subjects were seated in a chair in a relaxed posture, wearing glasses made of a rectangular sheet of the present invention approximately 20 cm x 3 cm wrapped around the strings.
- Subject I: Female in her 30s The measurement results obtained are shown in FIG. 23.
It can be seen that both delta waves and beta waves clearly decrease before and after wearing.
以上の実施例４－１から４－６の結果の通り、印刷等の手段を介して本発明の粉体組成物は適用した物品を身体に装着することで、手軽に確実なリラクゼーション効果を得ることが可能である。また同時に、これらの結果のように様々な物品に適用可能であるため、普段使い慣れた物品に適用すれば特別な使用を意識することなく効果を得ることが可能である。 As shown in the results of Examples 4-1 to 4-6 above, the powder composition of the present invention can easily provide a reliable relaxation effect by wearing the applied article on the body through means such as printing. Is possible. At the same time, as shown in these results, the method can be applied to a variety of products, so if it is applied to a product that is familiar to everyday use, it is possible to obtain effects without being conscious of special use.
＜血流促進効果の確認＞
本発明の粉体組成物の有する血流促進効果について、以下の試験により確認した。
試験５－１（腹まき）
実施例４の試験４－３で用いた腹まきを使用し、本発明の粉体組成物の有する血流促進効果について試験を行った。試験は、腹まきを装着時と未装着時の被験者の身体表面温度をサーモグラフィを用いて測定することで行った。結果を図２４～２７及び表５に示す。
サーモグラフィで得られる画像は色の違いによって温度の違いを表すものであるが、今回の試験では、身体表面のいくつかのポイントで測定温度を表示した。表５における「ポイント記号」とは対応する図に表示されている身体箇所を示すアルファベット小文字を意味している。
<Confirmation of blood flow promotion effect>
The blood flow promoting effect of the powder composition of the present invention was confirmed by the following test.
Test 5-1 (belly wrap)
Using the belly wrap used in Test 4-3 of Example 4, a test was conducted to determine the blood flow promoting effect of the powder composition of the present invention. The test was conducted by using thermography to measure the body surface temperature of the subjects while wearing and not wearing the belly wrap. The results are shown in FIGS. 24 to 27 and Table 5.
Images obtained with thermography use different colors to represent differences in temperature, but in this test, the measured temperatures were displayed at several points on the body surface. The "point symbol" in Table 5 means a lowercase letter of the alphabet indicating the body part displayed in the corresponding diagram.
試験は、最初に何も装着しない状態で元の体温を測定し（図２４）、次に本発明の粉体組成物を適用していない「未加工腹まき」を装着して（図２５）、身体の表面温度を測定した。更に、本発明の粉体組成物を適用した「加工済み腹まき」を装着してもらって（図２６）、身体の表面温度の測定を行った。尚、未加工品から加工品へ着替える際には、身体の表面温度が概ね元の温度に戻ってから加工品を装着してもらった。 In the test, the original body temperature was first measured without wearing anything (Figure 24), and then a "raw belly wrap" to which the powder composition of the present invention was not applied was worn (Figure 25). , the surface temperature of the body was measured. Furthermore, the subjects were asked to wear a "processed belly wrap" to which the powder composition of the present invention was applied (FIG. 26), and the surface temperature of their bodies was measured. In addition, when changing from an unprocessed item to a processed item, the processed item was put on after the surface temperature of the body returned to approximately the original temperature.
表５の温度［Ａ］欄は装着前の身体表面温度であり、［Ｂ］は未加工品装着時、［Ｃ］は本発明の加工品装着時の身体表面温度の測定値である。［Ｂ］－［Ａ］は、装着前と未加工品装着時の差であり、［Ｃ］－［Ａ］は装着前と加工品装着時の差である。そして、［Ｃ］－［Ｂ］は未加工品と加工品それぞれ装着時の身体表面温度の差を示す。この［Ｃ］－［Ｂ］欄の結果を見ると、本発明の粉体組成物を適用した腹まきを装着した場合には、未加工の腹まき装着時に比べて、０．３～１．６℃、平均０．８８℃身体の表面温度が高くなっていること分かる。また、未加工品では、当然ながら腹まきが触れていない首や脇下では身体表面温度の上昇が認められないのに対して、本発明の粉体組成物を適用した加工品では、身体全体で表面温度の上昇が認められ、単なる保温効果ではなく血流促進による身体の温め効果を示していることが分かる。身体の全体に渡って温度が上昇していることは図２６で示したサーモグラフィを見るとより明確である。 The temperature column [A] in Table 5 is the body surface temperature before wearing, [B] is the measured value of the body surface temperature when wearing the unprocessed product, and [C] is the measured value of the body surface temperature when wearing the processed product of the present invention. [B] - [A] is the difference before mounting and when the unprocessed product is mounted, and [C] - [A] is the difference between before mounting and when the processed product is mounted. [C]-[B] indicates the difference in body surface temperature when wearing the unprocessed product and the processed product, respectively. Looking at the results in columns [C]-[B], when wearing the belly wrap to which the powder composition of the present invention has been applied, the difference is 0.3 to 1. It can be seen that the surface temperature of the body has increased by 6 degrees Celsius, an average of 0.88 degrees Celsius. Furthermore, in the case of unprocessed products, no rise in body surface temperature was observed in the neck and armpits, which are not touched by the belly wrap, whereas in processed products to which the powder composition of the present invention was applied, the body surface temperature did not increase throughout the body. An increase in surface temperature was observed, indicating that the body warming effect is not just a heat retention effect, but a warming effect on the body by promoting blood flow. It is clearer from the thermography shown in FIG. 26 that the temperature is rising throughout the body.
図２７は、比較例である未加工品（左図）と本発明である加工品（右図）を装着した場合の温度分布を比較する図である。色の違いによって温度分布を示したカラー元画像における画像上の表示色を文字で示している。元画像では温度の高い順に赤－橙－黄－緑－紺－紫で示されている。図２７より、加工品では首回り（赤）、脇腹（橙）付近において、広い範囲で身体の表面温度が上昇していることが分かる。また胸部とへそ下の温度が低いことを示す紺の部分が、加工品では未加工品を装着した場合に比べてかなり狭い範囲となっている。その他の部分を比較しても、加工品の装着時は、未加工品を装着したときに比べて身体の全体に渡って表面温度が上昇したことが認められる。同じ面積、同じ素材の腹まきでありながら、本発明の粉体組成物を適用した腹まきを装着した場合には、このように身体全体で温度が上昇していることから、血流が促進されたことが伺える。 FIG. 27 is a diagram comparing the temperature distribution when an unprocessed product (left figure) as a comparative example and a processed product (right figure) according to the present invention are attached. The displayed colors on the image in the color original image showing the temperature distribution due to the difference in color are indicated by characters. In the original image, the colors are shown in descending order of temperature: red, orange, yellow, green, dark blue, and purple. From FIG. 27, it can be seen that the surface temperature of the body increases in a wide range around the neck (red) and flank (orange) in the processed product. Additionally, the dark blue area, which indicates the low temperature below the chest and navel, is much narrower with the processed version compared to when wearing the unprocessed version. Comparing other parts of the body, it was observed that the surface temperature increased throughout the body when wearing the processed product compared to when wearing the unprocessed product. Even though the area is the same and the material is the same, when wearing a belly wrap to which the powder composition of the present invention has been applied, the temperature rises throughout the body, which promotes blood flow. I can see that it was done.
試験５－２（ＩＤカードケース）
実施例４の試験４－４で用いたＩＤカードとほぼ同等の大きさの本発明シートをＩＤカードケースに入れたものを、被験者の首から掛けてもらい（図１５（ｃ）を参照）、装着前と装着から概ね１０分経過後の身体の表面温度をサーモグラフィを用いて測定した。結果は表６及び図２８～２９に示した。本出願では本来のカラー画像をモノクロに変換したものを添付する関係で、実施例５－１と同様にいくつかの測定ポイントについて位置を特定するアルファベット小文字と当該位置における測定温度を図中に表示した。表中の温度［Ｄ］欄は装着前、［Ｅ］欄は装着後の身体表面温度である。［Ｅ］－［Ｄ］はその差を示したものである。装着により全ての測定箇所で身体表面温度が上昇していることが分かる。また、図より明らかなように、実施例５－１の腹まきと同様に、シートが身体に触れている（接近している）箇所およびその周辺のみならず、腹部、首、脇の下等の大きな血管が通っている部分を中心に身体の全体で温度上昇が見られる。本実施例のＩＤカードケースは、実施例５－１の腹まきに比べて大幅に身体に接触する面積が小さいにも関わらず、このように身体全体に対して温め効果を示していることからも、単なる保温効果ではなく、血流促進によって身体が温まっていることが分かる。
Test 5-2 (ID card case)
A sheet of the present invention approximately the same size as the ID card used in Test 4-4 of Example 4 was placed in an ID card case, and the subject was asked to hang it around their neck (see Figure 15(c)). The surface temperature of the body was measured using thermography before wearing and approximately 10 minutes after wearing. The results are shown in Table 6 and Figures 28-29. In this application, the original color image is attached to a monochrome image, and the lowercase letters of the alphabet that specify the position of some measurement points and the measured temperature at the corresponding position are displayed in the figure as in Example 5-1. did. In the table, the temperature [D] column is the body surface temperature before wearing, and the [E] column is the body surface temperature after wearing. [E]-[D] shows the difference. It can be seen that the body surface temperature increases at all measurement points when worn. In addition, as is clear from the figure, similar to the belly wrap in Example 5-1, the seat covers not only the areas where the sheet touches (closes) the body and its surroundings, but also large areas such as the abdomen, neck, and armpits. An increase in temperature can be seen throughout the body, especially in areas where blood vessels pass. Although the ID card case of this example has a much smaller area of contact with the body than the belly wrap of Example 5-1, it has a warming effect on the entire body. It turns out that it doesn't just have a warming effect, but also warms the body by promoting blood flow.
実施例５－３(手の甲、手のひら）
本発明の粉体組成物を適用したシート（加工品）を概ね５ｃｍ×６ｃｍにカットしたものを、被験者の右手に貼付け、左手には粉体組成物が適用される前の帆布（未加工品）を同じ大きさにカットしたものを貼り付けてサーモグラフィを用いて表面温度の測定を行った。試験は、手のひらに貼付けた場合と、手の甲に貼り付けた場合について行った。シートを貼付けてから１０分経過後の表面温度の測定結果を、表７及び図３０～３１に示した。尚、測定試験は、１回の計測が終了した後に被験者からシートを外してから約２０分のインターバルを取り、被験者の表面温度が初期値に戻ったことを確認してから、次の測定を行った。
Example 5-3 (back of hand, palm)
A sheet (processed product) to which the powder composition of the present invention has been applied is cut into approximately 5 cm x 6 cm and pasted on the right hand of the subject. ) was cut to the same size and pasted on it, and the surface temperature was measured using thermography. Tests were conducted when the tape was attached to the palm of the hand and when it was attached to the back of the hand. Table 7 and FIGS. 30 to 31 show the measurement results of the surface temperature 10 minutes after the sheet was attached. In addition, in the measurement test, after one measurement was completed, the sheet was removed from the subject, and the next measurement was made after confirming that the subject's surface temperature had returned to the initial value. went.
表７に示した右手（加工品）と左手（未加工品）の温度差で明らかなように、未加工品に比べて加工品を貼り付けた方の手は、１．０℃前後の温度上昇が認められた。図３０及び３１から明らかなように、本実施例についても、加工品を貼り付けた箇所及びその周辺のみならず手のひらや手の甲全体で温度が上昇していることが分かる。このことから、加工品によって手の血流が促進されたことによって手全体の温度が上昇したものと考えられる。 As is clear from the temperature difference between the right hand (processed product) and left hand (unprocessed product) shown in Table 7, the temperature of the hand with the processed product pasted is around 1.0°C compared to the unprocessed product. An increase was observed. As is clear from FIGS. 30 and 31, it can be seen that in this example as well, the temperature increased not only at the location where the processed product was pasted and its surroundings, but also at the entire palm and back of the hand. From this, it is thought that the temperature of the entire hand increased as the blood flow in the hand was promoted by the processed product.
＜運動能力向上効果の試験＞
試験６－１（懸垂逆上がり）
被験者として、鉄棒の懸垂逆上がりができない１０代女性に協力頂き、本発明の粉体組成物を適用したシートを身体に装着することで運動能力の向上が見られるかを試験した。
試験は、最初にシートを全く装着しない状態で懸垂逆上がりに挑戦してもらい、次に、本発明のシートを身体に装着してもらって同様に懸垂逆上がりに挑戦してもらった。
更に、装着したシートを全て外して、未装着状態で３回目の挑戦を行い、その後に再度シートを身体に装着して４回目の挑戦をしてもらった。
<Test on the effect of improving athletic performance>
Test 6-1 (chin-up reverse)
As a test subject, we asked a female teenager who was unable to do a pull-up on a horizontal bar to test whether her athletic ability would be improved by wearing a sheet containing the powder composition of the present invention on her body.
In the test, the subjects first tried to do a pull-up backwards without any seat attached, and then had the subjects try to do a pull-up backwards while wearing the seat of the present invention on their bodies.
Furthermore, the subjects removed all the sheets they had put on and tried it a third time without wearing any sheets, and then had them put the sheets back on their bodies and try it a fourth time.
［結果］
第１回目（未装着）
懸垂後、両足を上へ伸ばして太ももを鉄棒に付ける動作までは問題なかったが、そこから鉄棒に体を巻きつけるように足を降ろして体を回転させる動作に入ることができず失敗となった。すぐに再挑戦を行ったが、結果は同様であった。懸垂逆上がりができるまであと一歩のところで失敗した感じとなった。
第２回目（装着）
５００円硬貨より一回り程大きい円状にカットしたシートを首の後ろに貼付け、約３ｃｍ×２．５ｃｍの長方形状にカットしてシートを両肘とへそ下に貼付けることで、本発明の粉体組成物を適用したシートを身体に装着した状態とした。この状態で、懸垂逆上がりに挑戦してもらった。
その結果、懸垂後に両足を上へ伸ばして太ももを鉄棒に付けたところで動作が止まってしまったが、そこでほんのわずかな間であるが踏ん張ることができ、次の動作である鉄棒に体を巻きつけるように足を降ろして体を回転させる動作に進むことができ、懸垂逆上がりを成功させることができた。
[result]
1st time (not installed)
After doing a pull-up, there was no problem until I stretched my legs upward and touched my thighs to the horizontal bar, but I was unable to lower my legs to wrap my body around the horizontal bar and rotate my body, resulting in a failure. Ta. I immediately tried again, but the result was the same. I felt like I was one step away from being able to do a reverse pull-up and failed.
2nd time (installation)
By pasting a sheet cut into a circle about one size larger than a 500 yen coin on the back of the neck, and cutting it into a rectangular shape of about 3 cm x 2.5 cm and pasting it on both elbows and below the navel, the present invention can be applied. The sheet to which the powder composition was applied was worn on the body. In this state, I asked them to try a reverse pull-up.
As a result, after a pull-up, the movement stopped when I stretched both legs upward and touched the horizontal bar with my thighs, but I was able to hold on for a short while and then wrapped my body around the horizontal bar for the next movement. I was able to move on to lowering my legs and rotating my body, and was able to successfully perform a reverse pull-up.
第３回目（未装着）
第２回目の挑戦後に、装着したシートを全て外してもらって、ふたたび未装着の状態で懸垂逆上がりに挑戦してもらった。
その結果、第１回目と同様に、両足を上へ伸ばして太ももを鉄棒に付ける動作までは進むものの、そこで力が入らずその先に動作に進むことができず失敗となった。
第４回目（装着）
第２回目での、首、両肘、へそ下に加えて横隔膜にも長方形状にカットしたシートを貼付けて、懸垂逆上がりに挑戦してもらった。その結果、両足を上へ伸ばして太ももを鉄棒に付けた後、ほとんど動作が止まることなく、次の鉄棒に体を巻きつけるように足を降ろして体を回転させる動作へとスムーズに進み、懸垂逆上がりを成功させた。被験者は、装着時は両足を上げた後、力を入れて次の体を巻きつける動作に入る際にスムーズに体が動いたとの感想を述べた。
3rd time (not installed)
After the second attempt, I had them remove all the sheets they had put on and try the pull-up again without the sheets on.
As a result, as in the first attempt, although he was able to extend his legs upward and touch his thighs to the horizontal bar, he was unable to move forward due to lack of strength at that point, resulting in a failure.
4th time (installation)
In the second session, participants attempted to do a reverse pull-up by pasting rectangular-shaped sheets on their necks, elbows, and below their navels, as well as on their diaphragms. As a result, after stretching both legs upward and touching the thighs to the horizontal bar, the movement smoothly progresses to the next horizontal bar by lowering the legs and rotating the body as if wrapping the body around the horizontal bar. He made a successful comeback. The test subject commented that when wearing the device, his body moved smoothly when he raised his legs and then put effort into the next movement of wrapping his body around himself.
試験６－２（陸上競技大会での使用）
陸上選手を被験者とし、本発明の粉体組成物を適用したシートを身体に装着して、2021年春に行われた競技大会に出場してもらった。シートは、一辺が数ｃｍ程度の方形や同程度の大きさの円形状のものを、各被験者が自身の競技パフォーマンスに支障がないと考える枚数、貼付け場所等を自由に決めて装着してもらった。
被験者の競技成績を表８に示した。１２被験者（個人１０名と各４名で構成された２チーム）が出場し、その内の７被験者が自己新記録若しくはシーズンベストを記録した。
Test 6-2 (use in track and field competitions)
Track and field athletes were used as subjects, and they wore sheets to which the powder composition of the present invention was applied, and had them participate in a competition held in the spring of 2021. The sheets may be rectangular with a side of several centimeters or circular sheets of similar size, and each subject was asked to freely decide on the number of sheets and where to attach them as they thought would not interfere with his or her competitive performance. Ta.
The competition results of the subjects are shown in Table 8. Twelve subjects (10 individuals and 2 teams of 4 people each) participated, and 7 of them set new personal records or season bests.
以上のように、本発明の粉体組成物は、その神経コンディショニング効果により、優れた「血流促進、リラクゼーション及び運動能力向上」効果を発揮するものである。
医学博士・篠浦伸禎医師の考察によれば、本発明の粉体組成物の作用機序は次のように考えられる。ストレスや有害物質、損傷などの影響を受け、神経のコンディションは必ずしも万全ではない。いわば神経が不健康な状態であり、それによって様々な体の不都合が発生する。逆に言えば、神経のコンディションを整えることで健康な状態となれば、例えば自律神経の切り換えがスムーズになる等の現象が生じることは自明である。
As described above, the powder composition of the present invention exhibits excellent "blood flow promotion, relaxation, and exercise performance improvement" effects due to its nerve conditioning effect.
According to the considerations of Dr. Nobutaka Shinoura, a medical doctor, the mechanism of action of the powder composition of the present invention is thought to be as follows. Nerves are not always in perfect condition due to the effects of stress, harmful substances, and injuries. In other words, the nerves are in an unhealthy state, which causes various physical problems. Conversely, it is obvious that if the condition of the nerves is adjusted to achieve a healthy state, phenomena such as smooth switching of the autonomic nervous system will occur.
ここで、「神経のコンディションが整う」とは、神経線維の電位が乱れていた部分が整うことであり、その結果、命令伝達がスムーズになると考えられる。
電位配置の乱れは知覚神経と運動神経である体性神経の情報伝達に不具合を生じ、反応が鈍くなる等、いわゆるパフォーマンスの低下を招くこととなる。本発明の粉体組成物を適用した物品を装着することでこうした状態が改善される事例は、神経のコンディションが改善されていることを示唆するものある。
また同時に、本発明の粉体組成物を適用した物品を身体に装着することで、副交感神経優位に誘導される傾向を持った脳波変化が再現性をもって現れることも事実としてある。
Here, "the condition of the nerves is adjusted" means that the parts where the electric potential of the nerve fibers was disordered are adjusted, and as a result, it is thought that the transmission of commands becomes smoother.
Disturbances in the potential arrangement cause problems in the transmission of information between sensory nerves and somatic nerves, which are motor nerves, resulting in a so-called decline in performance, such as slowed responses. There are cases where such conditions are improved by wearing an article to which the powder composition of the present invention is applied, suggesting that the condition of the nerves is improved.
At the same time, it is also a fact that when an article to which the powder composition of the present invention is applied is worn on the body, brain wave changes that tend to be induced by parasympathetic nerves appear with reproducibility.
本発明の粉体組成物の働きは以下のように考察される。粉体組成物から発せられる微弱電磁波が末梢神経を刺激することで神経のコンディションが整う。ここで神経構造について考えると、神経細胞の軸索は、密な膜構造である髄鞘により何重にも取り囲まれている。髄鞘は脂質に富み絶縁体として働く。髄鞘は軸索全体を覆っているのではなく、ところどころくびれて消失していることにより一定の間隔が開いたものである。この隙間は、ランビエ絞輪（ｎｏｄｅ ｏｆ Ｒａｎｖｉｅｒ）と呼ばれ、この部分でしか活動電位を発生させることができない。 The function of the powder composition of the present invention is considered as follows. The weak electromagnetic waves emitted from the powder composition stimulate the peripheral nerves, improving the condition of the nerves. Considering the structure of nerve cells, the axons of nerve cells are surrounded by multiple layers of myelin sheath, which is a dense membrane structure. The myelin sheath is rich in lipids and acts as an insulator. The myelin sheath does not cover the entire axon, but is constricted and lost at certain intervals, leaving certain intervals. This gap is called a node of Ranvier, and an action potential can only be generated in this portion.
図３２の（ａ）は、神経線維の電位配列が正常な状態を示している。図３２（ｂ）は、興奮部が存在することで、興奮部（１）から興奮部（２）への電流（命令）の流れが阻害されている状態を示す。このように、絞輪部の電位配列が狂っていると電流が流れず命令が伝わらないことになる。本発明の粉体組成物から発せられる微弱電磁波は神経を刺激し、電位配列を正常化させる働きを持つと考えられる。これにより、神経の伝達がスムーズになり、上記のような各種効果となって表れる。
このように神経のコンディションが整うことで、神経の命令伝達が届かなかった末梢神経にも命令が届くようになる。このような働きの結果、老犬の歩行改善や重心バランスの安定、運動パフォーマンスの向上といった現象が効果として表れることとなる。
また、神経のコンディションが整うことで、神経の乱れによるストレスが軽減され、副交感神経優位にスイッチし易い状態になることも脳波データから読み取れるものである。
FIG. 32(a) shows a state in which the potential arrangement of nerve fibers is normal. FIG. 32(b) shows a state where the flow of current (command) from the exciting part (1) to the exciting part (2) is obstructed by the presence of the exciting part. In this way, if the potential arrangement of the throttle ring is out of order, no current will flow and commands will not be transmitted. The weak electromagnetic waves emitted from the powder composition of the present invention are thought to have the function of stimulating nerves and normalizing the potential arrangement. As a result, nerve transmission becomes smoother, resulting in the various effects mentioned above.
By improving the condition of the nerves in this way, commands can now reach peripheral nerves that previously could not be reached. As a result of this action, phenomena such as improved gait, stable center of gravity balance, and improved athletic performance will appear as effects in older dogs.
In addition, it can be seen from the brain wave data that by adjusting the condition of the nerves, the stress caused by disturbances in the nerves is reduced, and it becomes easier to switch to the parasympathetic nervous system.
本発明の粉体組成物を用いれば、種々の物品に対して血流促進作用、リラクゼーション及び運動能力向上の効果を付与することが可能となるため、服飾品、健康用品、スポーツ器具、建築材料等を始めとする幅広い分野において利用可能である。 By using the powder composition of the present invention, it is possible to impart effects of promoting blood flow, relaxation, and improving athletic performance to various articles, such as clothing, health products, sports equipment, and building materials. It can be used in a wide range of fields, including
１ 靴用中敷（インソール）
１１ インソール本体（帆布）
１２ 印刷されたパターン
２ シート
２１ シート本体（布）
２２ 印刷されたパターン
1 Insole for shoes
11 Insole body (canvas)
12 Printed pattern 2 Sheet 21 Sheet body (cloth)
22 Printed pattern
Claims (6)
前記微粉末状の炭化紛は、天然植物材料を、焼成時間２～４時間の間で選ばれた任意の設定時間において、当該設定時間内に炭化させるために必要な焼成温度を８００～１２００℃の間から選択し、当該選択された温度と前記設定時間を焼成条件として加熱することにより得られた炭化物を微粉末状に粉砕したものであることを特徴とする、
血流促進用、又は脳波をリラックス状態へ遷移させるリラクゼーション用粉体組成物。 Containing 5 to 50 parts by weight of finely powdered carbonized powder per 1 part by weight of finely powdered radium ,
The carbonized powder in the form of fine powder is prepared by heating the natural plant material at a firing temperature of 800 to 1200°C, which is necessary to carbonize the natural plant material within the set time of 2 to 4 hours. The carbide obtained by heating at the selected temperature and the set time as firing conditions is pulverized into a fine powder.
A powder composition for relaxation that promotes blood flow or shifts brain waves to a relaxed state.
天然植物材料を、焼成時間２～４時間の間で選ばれた任意の設定時間において、当該設定時間内に炭化させるために必要な焼成温度を８００～１２００℃の間から選択し、当該選択された温度と前記設定時間を焼成条件として加熱して得た炭化物を粉砕することにより微粉末状の炭化粉を作成し、
前記粉砕物と炭化粉とを混合することにより粉体組成物を作成することを特徴とする、請求項１に記載の粉体組成物の製造方法。 In addition to crushing radium-containing ores to create a fine powder,
Select the firing temperature necessary for carbonizing the natural plant material within the set time from 800 to 1200°C at any set time selected from the range of 2 to 4 hours, and A finely powdered carbonized powder is created by pulverizing the carbide obtained by heating at the temperature and the set time as firing conditions ,
2. The method for producing a powder composition according to claim 1, wherein the powder composition is prepared by mixing the pulverized material and carbonized powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021212987A JP7385643B2 (en) | 2021-12-27 | 2021-12-27 | Powder composition for promoting blood flow, relaxation, and improving athletic performance, its manufacturing method, and its use |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021212987A JP7385643B2 (en) | 2021-12-27 | 2021-12-27 | Powder composition for promoting blood flow, relaxation, and improving athletic performance, its manufacturing method, and its use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023096920A JP2023096920A (en) | 2023-07-07 |
| JP7385643B2 true JP7385643B2 (en) | 2023-11-22 |
Family
ID=87005414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021212987A Active JP7385643B2 (en) | 2021-12-27 | 2021-12-27 | Powder composition for promoting blood flow, relaxation, and improving athletic performance, its manufacturing method, and its use |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7385643B2 (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007153642A (en) | 2005-12-01 | 2007-06-21 | Jiro Shimizu | Method for manufacturing radioactive ceramic board and radioactive bedrock bath sheet, and ceramic board bath apparatus |
| JP2007197569A (en) | 2006-01-26 | 2007-08-09 | Nakagawa Yoshie | Resin material and molding using the resin material |
| JP2021176348A (en) | 2020-05-07 | 2021-11-11 | 株式会社ナチュラルアビリティ | Powder composition for stabilizing physical gravity center, and its manufacturing method and its use |
-
2021
- 2021-12-27 JP JP2021212987A patent/JP7385643B2/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007153642A (en) | 2005-12-01 | 2007-06-21 | Jiro Shimizu | Method for manufacturing radioactive ceramic board and radioactive bedrock bath sheet, and ceramic board bath apparatus |
| JP2007197569A (en) | 2006-01-26 | 2007-08-09 | Nakagawa Yoshie | Resin material and molding using the resin material |
| JP2021176348A (en) | 2020-05-07 | 2021-11-11 | 株式会社ナチュラルアビリティ | Powder composition for stabilizing physical gravity center, and its manufacturing method and its use |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023096920A (en) | 2023-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ogaya et al. | Effects of balance training using wobble boards in the elderly | |
| KR102613281B1 (en) | Bioceramic compositions and biomodulatory uses thereof | |
| Huguenin et al. | Effect of dry needling of gluteal muscles on straight leg raise: a randomised, placebo controlled, double blind trial | |
| Movaffaghi et al. | Effects of therapeutic touch on blood hemoglobin and hematocrit level | |
| Fedorowich et al. | The effect of walking while typing on neck/shoulder patterns | |
| Cabak et al. | Preventive chair massage with algometry to maintain psychosomatic balance in white-collar workers | |
| JP7385643B2 (en) | Powder composition for promoting blood flow, relaxation, and improving athletic performance, its manufacturing method, and its use | |
| Guo et al. | The effect of arm support and control modes on muscle fatigue, eye fatigue, and posture changes in mobile game use among young adults | |
| KR100479195B1 (en) | The massage pillow containing functional fiber | |
| Calatayud et al. | Electromyographic effect of using different attentional foci during the front plank exercise | |
| US11413185B2 (en) | Therapeutic textile articles and methods of use | |
| KR102284898B1 (en) | Chair providing electrical stimulation | |
| Peper et al. | Posture and mood: Implications and applications to therapy | |
| Shao et al. | Surface EMG based muscle fatigue evaluation on neck-shoulder muscles while using single-monitor arm | |
| Rodrigues et al. | Effects of anodal transcranial direct current stimulation on training volume and pleasure responses in the back squat exercise following a bench press | |
| de Carvalho et al. | Acupuncture improves flexibility: acute effect of acupuncture before a static stretch of hip adductors | |
| Montgomery | End Your Carpal Tunnel Pain Without Surgery | |
| Stone | The world's best massage techniques the complete illustrated guide: Innovative bodywork practices from around the globe for pleasure, relaxation, and pain relief | |
| CN111109963A (en) | Bedding structure with non-power energy layer and far infrared fiber | |
| Husaini et al. | Control design of vibrotactile stimulation on weighted vest for deep pressure therapy | |
| Smith et al. | Crs Computer-Related Syndrome: The Prevention & Treatment of Computer-Related Injuries | |
| Song et al. | Study on the Effect of Cervical Spine Somatosensory Games of Virtual Reality and Augmented Reality on Relieving Neck Muscle Fatigue | |
| CN215838018U (en) | Side sleeping riding pillow | |
| Léger | Does active sitting provide more physiological and biomechanical benefits than traditional sitting and standing workstations? | |
| Fetsch et al. | Prevention of Work-Related Musculoskeletal Disorders Among Individuals Utilizing a Home Computer Workstation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220121 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20220121 |
|
| A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A80 Effective date: 20220126 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220517 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20220719 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220916 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221207 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230203 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230405 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230614 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230810 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20231108 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20231110 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7385643 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |